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Vertically aligned carbon nanofiber (VACNF) arrays have been developed as a novel tool 
for direct physical introduction and expression of DNA in mammalian cells (termed 
impalefection).  This study describes the optimization of impalefection, the quantification 
of immobilized DNA on VACNFs, and the application of VACNFs in analysing gene 
expression in mammalian cells.  Mechanical, chemical and biological parameters were 
optimized for impalefection.  Alterations in a majority of the parameters resulted in no 
significant difference in impalefection efficiency, including nanofiber composition, DNA 
precipitation, cell confluency, cell concentration and sodium butyrate.  The optimal DNA 
concentration ranged between 100 nanograms and 1 microgram, and the optimal 
impalefection substrate proved to be a Durx filter pad on plastic surface.  High levels of 
efficiency in a wide range of mammalian cell lines demonstrated the versatile 
applicability of the impalefection method.  Polymerase chain reaction (PCR) and in-vitro 
transcription (IVT) were used to investigate the transcriptional accessibility of 
immobilized DNA on VACNF arrays by correlating the yields of both IVT and PCR to 
that of non-immobilized DNA.  Quantitative PCR was used to quantify the number of 
accessible yfp reporter gene copies immobilized to nanofiber arrays.  DNA yields 
decreased dramatically in the non-immobilized control over time, while the majority of 
immobilized DNA was retained on VACNF arrays.  These data demonstrated the 
development of methods for monitoring DNA immobilization techniques.  To validate 
the applicability of VACNF arrays for controlling and monitoring mammalian gene 
expression, a tetracycline-inducible shRNA vector system was designed for silencing 
 vi
CFP expression and was impalefected into mammalian cells.  VACNF arrays provided 
simultaneous delivery of multiple genes, subsequent adherence and proliferation of cells, 
and repeated monitoring of single cells over time.  Following impalefection and 
tetracycline induction, 53.1% ± 10.4% of impalefected cells were fully silenced by the 
inducible shRNA vector.  Additionally, efficient CFP-silencing was observed in single 
cells among a population of cells that remained CFP-expressing.  This effective transient 
expression system enabled rapid analysis of gene silencing effects using RNAi in single 
cells and cell populations. 
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What is Nanotechnology? 
 
Science and technology have made substantial strides of progress in the last few decades.  
The number of technological advances is increasing exponentially, and the applications 
of these new technologies to scientific knowledge are making a significant impact 
worldwide.  Nanotechnology is one example of a technology that has made a major 
contribution on the scientific community.  Although the interdisciplinary field of 
nanotechnology has been widely recognized only in the last decade or so, science at the 
nanoscale has been addressed for almost half a century.  Most notable is Richard 
Feynman’s famous and somewhat prophetic invitation given at the annual meeting of the 
American Physical Society in 1959, “There’s Plenty of Room at the Bottom,” in which he 
predicted that future scientists would have the ability to manipulate single molecules and 
atoms and arrange them into desirable materials (Feynman 1959).  The term 
“nanotechnology” was first coined by Norio Taniguchi at the Tokyo Science University 
in 1974 as consisting of “…the processing of separation, consolidation, and deformation 
of materials by one atom or one molecule…“ (Taniguchi 1974).  Nanotechnology is 
defined by the National Research Council in the National Nanotechnology Initiative as “. 
. . research and technology development at the atomic, molecular, or macromolecular 
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levels, in the length scale of approximately 1-100 nanometer range, to provide a 
fundamental understanding of phenomena and materials properties at the nanoscale and 
to model, create, characterize, manipulate, and use structures, devices, and systems that 
have novel properties and functions because of their small or intermediate size” (NRC 
2002).  One advantage of nanofabrication is that devices are typically structured from the 
“bottom-up” approach rather than the traditional method of “top-down”.  As implied, this 
means that construction occurs by beginning with a blank platform and assembling one 
molecule at a time, rather than having to shape a device out of an already existing 
structure.  This ordered assembly as opposed to controlled deconstruction can often be 
much more energy efficient (Masciangioli and Zhang 2003).  Although the term 
nanotechnology is generally understood by scientists, it proves to be somewhat arbitrary.  
In a survey conducted by 3i in association with the Economist Intelligence Unit and the 
Institute of Nanotechnology, experts in the field of nanotechnology (e.g. corporate 
researchers, academic researchers, investors, venture capitalists, analysts, consultants) 
were asked how they would define nanotechnology.  Although most individuals had a 
general idea of defined nanotechnology, not all could agree on where the nanoscale 
domain begins.  Approximately half of those interviewed agreed that nanotechnology was 
limited to less than 100 nm, while 25 percent of those interviewed restricted 
nanotechnology to the atomic and molecular level (Pitkethly 2003).   However, a much 
wider definition is warranted, where functionality is imparted or augmented by 
components of a system that exist at the nanoscale (<100 nm). 
 
 3
We are now in the middle of a new scientific age, where nanotechnology is exploding in 
its stages of development and application.  The application of nanotechnology has 
facilitated a union between many fields of research, including, but not limited to: 
computer science, materials science, engineering, physics, microscopy, medicine, 
microbiology, biochemistry, and molecular biology.  There are also a number of products 
with nanotechnological aspects to them that have entered the consumer market (Liu et al. 
2006; Nohynek et al. 2007; Tsuji et al. 2006).  Due to their efficiency at absorbing light – 
particularly in the ultraviolet (UV) range – nanoparticles have been successfully 
marketed in Australian sunscreen lotions (Wilkinson 2003).  In fact, over 60% of the 
Australian sunscreen industry has adapted to the addition of nanoparticles, and this same 
trend is expected to soon be seen in Europe and the United States as well (CSIRO 2004).  
Other consumer-related products include nano-thin magnetic material layers in computer 
hard drives that result in increased storage capacity, protective paints and coatings that 
resist corrosion and radiation, stain-free clothing, bonding agents for dentistry, and car 
bumpers that are stronger - while at the same time - more flexible (NNI 2004).  While the 
application of nanotechnology in consumer products has resulted in incremental 
advances, the truly dramatic impact of nanotechnology’s possibility lies in its more 





Nanotoxicology:  An Emerging Field 
 
With any new developing technology comes new concerns and cautions to shed light on 
the environmental and toxicological impacts of the technology and to guarantee that it is 
used responsibly.  Although restrictions are often placed on research by scientists 
themselves, sometimes more strict restraints are needed.  This was seen in the 1970's, 
when legal and moral restraints were placed on biotechnology and genetic research by the 
government in an effort to address potential and perceived harms of these fields on 
society in general (OTA.  Office of Technology Assessment 1984).  It was a concern at 
the time that cloning and genetic modification could do more harm than good in the long 
run, and government intervention was used to keep the scientific community accountable.  
While nanotechnology continues to gain more interest in the public eye, it is important to 
understand the impact it will have on society, and create more defined boundaries and 
regulations if needed.  This has resulted in the emergence of a new field termed 
nanotoxicology.   
 
It is worth mentioning that the toxicological effects of nanoparticles (which is a more 
recent term; also referred to as ultrafine particles or particulate matter) in emissions, 
from coal mines, and simply in the atmosphere, have been long studied (Davis et al. 
1982; McClellan et al. 1982; Oberdorster et al. 1994).  However, clarification needs to be 
made to keep from grouping newly engineered nanoparticles into the same category as 
nanoscaled particulate matter.  Therefore, nanotoxicology in this section will address the 
toxicological effects of engineered nanostructures, due to its specific relevance to this 
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work.  Thorough reviews by Borm and Oberdorster discuss the links between the 
historical foundation and progress of particle research with the rapidly growing field of 
nanotechnology (Borm 2002; Oberdorster et al. 2005).   
 
The biggest hurdle with discussing the potential risks of nanotechnology is the fact that 
this area of technology is extremely novel and the impacts remain to be understood.  
However, based on sparse preliminary experiments that suggest some nanostructures can 
be harmful to biological systems, there has been an enormous call for research in this 
area.  In light of the potential market and practical applications of nanotechnology, it is 
generally recognized that these environmental and health impacts must be addressed.  
The economy of nanotechnology is projected to be valued at $1 trillion by 2012 
(Hardman 2006), and the U.S. Congress has encouraged billions of dollars of funding on 
research devoted to the medical and environmental impacts of the new technology (Giles 
2003).  There are many aspects to the possible risks that nanotechnology introduces, due 
to the fact that nanotechnology is potentially useful to so many different disciplines.  
There are medical concerns such as whether nanoparticles should be used for applications 
in humans, and there are environmental issues such as the problem of releasing copious 
amounts of nanostructures into nature.  As Colvin emphasized in a recent review, it is 
important to realize that any substance can be toxic at a given exposure level (Colvin 
2003).  However, with the growing demand for nanofabricated structures comes a 
growing demand for protecting workers in the field of nanotechnology.  For example, 
Mitsubishi opened a fullerene-producing plant in Japan in May 2003, which produces 
many tons of fullerene particles every year (Colvin 2003).  These plant workers will all 
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potentially be exposed to nanomaterials, as will the consumers that buy products 
containing an ever-increasing amount of nanomaterials.  Furthermore, these 
nanostructures will eventually find their way into the groundwater and soil, since the 
increase of artificial substances in the environment is directly proportional to the use of 
such substances by society (Colvin 2003).   
 
The body of experimental evidence showing the cytotoxic effects of nanomaterials is 
growing.  Johnston et al. showed that Teflon (PTFE) nanoparticles result in pulmonary 
toxicity when laboratory animals are exposed intratracheally (Johnston et al. 2000).  
Interestingly, Teflon nanoparticles approximately 16 nanometers in diameter were toxic, 
while nanoparticles >100 nanometers lost their toxic effect.  This suggests the unique 
toxicology that nanoparticles introduce.  Early studies also demonstrated that carbon 
nanotubes (2-50 nm) and nanoparticles (20-30 nm) can result in acute inflammatory 
pulmonary effects including granuloma formation in rats (Warheit et al. 2004) and mice 
(Lam et al. 2004), and can ultimately translocate to the liver (Oberdorster et al. 2002).  
Similar toxicological responses have been seen in cultured cells using titanium dioxide 
nanoparticles (Wang et al. 2007), C60 (Sayes et al. 2005),  single wall carbon nanotubes 
(SWNTs) (Shvedova et al. 2004) and multi-wall carbon nanotubes (MWNTs) (Monteiro-
Riviere et al. 2005).  Oberdorster et al. demonstrated that carbon nanoparticles travel to 
the brain upon inhalation in laboratory rats (Oberdorster et al. 2004).  However, this 
study did not imply that the nanoparticles were toxic upon translocation to the brain.  A 
different study, exposing largemouth bass to uncoated C60, suggested that these 
nanoparticles can not only travel to the brain upon inhalation, but can subsequently result 
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in oxidative stress and damage to the brain (Oberdorster 2004).  A more recent in vitro 
investigation showed that fullerene (C60 carbon nanoparticles) derivatives bind to beta-
lactoglobulin and are transferred to human serum albumin, suggesting a theoretical 
pathway for how carbon nanomaterials interact on the molecular level and are transported 
in biological systems (Belgorodsky et al. 2007).  However, many early studies that 
showed cytotoxic effects were using large doses of carbon nanostructures and could have 
resulted in death not due to the nanostructure, but due to obstruction of the lungs 
(Oberdorster et al. 2005).  In addition, Henry et al. have recently demonstrated that C60 
particles solubilized in tetrahydrofuran (THF), a common vehicle solvent used in 
nanotoxicology studies, may have cytotoxic effects in larval zebrafish not due to the 
carbon nanomaterials themselves, but strictly due to a THF degradation product, γ-
butyrolactone (Henry et al. 2007).  The aggregation state and metal impurities of 
preparations have also been proposed as contributions to the observed cytotoxicity of 
carbon nanostructures (Oberdorster et al. 2005).  Very few studies have investigated the 
ecotoxicological effects of nanostructures.  Zhu et al. demonstrated that C60-exposed 
Daphnia showed an LC50 of >35 ppm, and fathead minnow showed no physical effects 
at 48 hours (Zhu et al. 2006).  However, lipid peroxidation significantly increased in 
fathead minnows as a result of C60 exposure. 
 
More conclusive data is needed to fully understand the toxic effects of nanostructured 
materials.  Most carbon nanostructures – single-walled nanotubes, fullerenes, and carbon 
nanoparticles – and quantum dots are in the process of risk assessment.  While substances 
such as dendrimers and silica nanoparticles are considered relatively harmless due to their 
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biocompatible and biodegradable nature, there are many other engineered nanoparticles 
of differing compositions that need to be studied including iron and bimetallic 
nanoparticles, which are potential candidates for future in situ remediation.  Likewise, no 
toxicological studies have been pursued for carbon nanofibers or vertically aligned 
carbon nanofibers (VACNFs).  Nanotoxicology will continue to be a growing field, given 
the high demand for knowledge and literature on the toxicity and long-term exposure 
effects of nanostructured materials on medical fields and the environment. 
 
The Promise of Nanotechnology in the Biological Realm 
 
Currently, one of the primary scopes of nanotechnology is the arena of biological 
sciences.  The biological applications of nanostructures have been as broad as the shape 
of the structures themselves.  To highlight just a few applications, we will look at the 
application of nanomaterials to targeted drug delivery, molecular imaging, and gene 
delivery. 
 
As stable, spectrally discrete, and chemically functional elements, nanoparticles provide 
unique characteristics for interfacing with biological systems at the molecular scale.  The 
ability to generate particles that are spectrally discrete enables probing of the 
nanoparticles upon delivery, and through functionalization, they can be employed for 
material delivery applications. An elegant approach has been demonstrated by Salem et 
al. where a bimodal nanoparticle (nickel-gold) provided both material retention and 
nuclear targeting, enabling directed transport of genetic material to the nuclear domain 
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(Salem et al. 2003).  In addition to subcellular scale targeting, such bimodality can also 
be used for targeting specific organs of the patient, thus carrying the drug to the area of 
treatment while also potentially masquerading the drug from degradation pathways which 
can result in pharmaceutical break down and the commensurate requirement for larger 
dosing (Shaffer 2005).  Previously there has been limited success in efficiently delivering 
drugs to the brain, due to the blood-brain barrier.  However, nanoparticles have shown 
promise to researchers in this area, due to the ability to coat the nanoparticle and 
“disguise” the drugs being delivered.  Lockman et al. injected 100 nm thiamine-coated 
nanoparticles comprised of emulsifying wax and polyoxyl 20-stearyl ether into rats, 
showing that the use of the thiamine ligand on the surface of the nanoparticles helped 
facilitate binding with the blood-brain barrier transporters, thus successfully delivering 
the nanoparticles to the brain (Lockman et al. 2003).  The ultimate goal is to use these 
nanoparticles as a tool for localized drug delivery to target and treat tumors in the brain. 
 
Quantum dots continue to be the most widely applied nanoparticles in the biological 
field. Quantum dots are engineered from heavy metals, such as cadmium selenide 
(CdSe), and are often coated with a polymer that provides biocompatibility or molecular 
targeting for use in cell labeling, cell-tracking, and in vivo imaging (Alivisatos 2004).  
The core size of quantum dots is typically 5-6 nanometers.  Once the CdSe core is 
layered with a polymer coating and then conjugated with specific molecules for 
biological recognition (proteins, DNA, antibodies), the typical size of the quantum dot 
while interacting with the aqueous solution is close to 25 nanometers (Zipfel 2004).  The 
fluorescent capabilities of these semiconductor nanocrystals far outweigh any 
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conventional molecular fluorophores or fluorescent dyes (Alivisatos 2004).  The emission 
spectra of quantum dots can be finely tuned, providing spectrally discrete emission from 
individual nanoparticles and the ability to track multiple molecular events within 
biological systems simultaneously using a single source of excitation. Furthermore, 
unlike many traditional fluorophores, quantum dots are not easily photobleached and 
provide long-term stability. They have recently been linked to antibodies and used for in 
vitro detection of enteric pathogens such as Cryptosporidium parvum and Giardia 
lamblia (Zhu et al. 2004a), as well as in vivo targeting and detection of tumors in live 
animals (Chan and Nie 1998).  Additionally, Wiesner et al. are working on developing 
silica particles that can be used for binding specific molecules, and then tracking their 
respective pathways in humans (Wiesner 2004).  Due to their radiative properties, they 
have fluorescence levels similar to quantum dots.  Additionally, the biocompatibility of 
silica particles gives them an advantage over quantum dots for human applications.  
Likewise, they are easily and inexpensively made using well established synthesis 
techniques, including sol gel-based methodologies (Ow et al. 2004).  However, typical 
silica nanoparticles are hundreds of nanometers in diameter, rendering them incapable for 
efficient molecular delivery to specific antibodies or protein receptors. Wiesner et al have 
been able to construct silica nanoparticles down to the size of 30 nanometers, that are 20 
times brighter and more photostable than traditional fluorescent dyes and molecular 
fluorophores (Ow et al. 2005).  Because 30 nanometers is still too large for silica 
nanoparticles to be linked with specific antibodies and proteins (Garman et al. 2000), 
progress is still underway to develop even smaller silica particles.   
 
 11
DNA delivery to mammalian cells has become a staple of biological studies in the last 
few decades, and a crucial means of determining gene function and gene pathways.  A 
number of nanostructured platforms have been shown to effectively deliver plasmid DNA 
into multiple mammalian cell types.  While a number of organic and biodegradable 
particles have been used for DNA complexation and delivery (Batard et al. 2001; 
Chowdhury and Akaike 2005b; Hedley and Barman 2004; Nie and Wang 2007), 
inorganic nanostructures can offer additional stability to the DNA during nuclear 
transport (Chowdhury and Akaike 2005a).  These include nanoparticles, nanoscaffolds, 
nanorods, nanofibers and nanotubes.  Silica nanoparticles have been synthesized and 
complexed with DNA for efficient gene delivery.  The surface of the silica nanoparticle 
can be modified with poly(L-lysine) (Zhu et al. 2004b) or aminoalkylsilanes (Kneuer et 
al. 2000) to electrostatically interact with the DNA and protect it from enzymatic 
degradation, and allowing controlled release of the DNA from the silica nanoparticle 
within the cell (Roy et al. 2005).  Uchimura et al. used gold colloid nanoparticles as a 
negatively charged nanoscaffold for increasing the uptake of DNA in human 
mesenchymal stem cells (Uchimura et al. 2007).  The 20 nanometer gold nanoparticles 
increased the transfection efficiency to levels 2.5-fold higher than the same technique in 
the absence of gold nanoparticles.  Bifunctional nanorods were first introduced by Salem 
et al. (Salem et al. 2003).  These particles were 200 nm in length, composed of discrete 
nickel and gold regions.  DNA was linked to the nickel and thiol groups containing 
transferrin were linked to the gold.  This resulted in increased efficiency of DNA uptake 
in HEK293 cells, and has potential for targeted DNA delivery in the future.   
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Recent demonstrations have shown that vertically aligned carbon nanofiber arrays 
(VACNFs) grown on a silicon substrate can be used as a gene delivery platform in 
mammalian cells (McKnight et al. 2003a; McKnight et al. 2004b).  This nanofiber-
mediated gene delivery method, referred to as impalefection, will be discussed in more 
detail below.  Cai et al. have demonstrated an approach similar to impalefection, termed 
nanospearing, in which carbon nanotubes impale mammalian cells due to magnetic 
agitation (Cai et al. 2005b).  Nanospearing has proven to be highly efficient, resulting in 
80%-100% efficiency of gene delivery and expression.  Likewise, Cai et al. have recently 
shown that carbon nanotubes are biocompatible with cultured cells and can transfer genes 
into primary cell lines that are traditionally hard to transfect (Cai et al. 2007). 
 
Additional nanomaterials that have incorporated into biology include biocompatible and 
robust nanolayers as coatings for orthopedic implants (Chun et al. 2004; Price et al. 2003; 
Webster et al. 2004), silver nanomaterials for antibacterial wound dressings (Kim et al. 
2007), iron oxide nanoparticles for MRI contrast agents (Pitkethly 2003), nanostructured 
surfaces for neuronal outgrowth and patterning (Dowell-Mesfin et al. 2004), and 
nanoscale aerosols for lung inhalation therapies (Courrier et al. 2002). 
 
Vertically Aligned Carbon Nanofibers as a Tool of Nanobiotechnology 
 
Carbon nanofibers have become an invaluable tool for nanobiotechnology in the last 
decade.  Although carbon nanofibers have long been the product of interacting 
carbonaceous gas and metal catalysts, the deterministic synthesis of carbon nanofibers 
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has existed for less than 20 years.  As Melechko pointed out in his excellent review, 
deterministic synthesis refers to the fact that the diameter, position, alignment, length and 
chemical composition of the nanofiber can be controlled (Melechko et al. 2005).  Chen et 
al. were the first group to use catalytic plasma enhanced chemical vapor deposition (C-
PECVD) for the synthesis of carbon nanofibers (Chen et al. 1997).  However, growth of 
nanofibers can be achieved using additional methods of chemical vapor deposition, such 
as catalytic thermal chemical vapor deposition (C-TCVD).   
 
Carbon nanofibers (CNFs) are defined as conical structures that typically have a high 
aspect ratio, meaning that the diameter of the structure can be between tens and hundreds 
of nanometers while the length of the structure can range from hundreds of nanometers to 
a few millimeters (Meyyappan et al. 2003).  The internal structure of the CNF consists of 
graphene sheets containing a hexagonal repeating pattern of carbon atoms covalently 
bound together (Melechko et al. 2005).  The graphene sheets are arranged in a stacked-
cone composition with exposed edges of unsaturated bonds.  Nolan et al. note that 
hydrogen can be added during the growth process of CNFs to fulfill the valences at the 
graphene edges (Nolan et al. 1998).   This composition differs widely from the more 
popular carbon nanotubes (CNTs).  CNTs consist of graphene sheets rolled up into 
concentric cylinders with no exposed edges, which gives CNTs much less reactivity than 
CNFs (Meyyappan et al. 2003).   
 
Vertically aligned carbon nanofibers (VACNFs) refer to CNFs that have been grown 
perpendicular to the substrate surface.  This can be achieved during PECVD, due to the 
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placement of the catalyst particle and the interaction with the electric field (Merkulov et 
al. 2001).  The growth and conditions of vertically aligned carbon nanofibers can vary 
from process to process (Cojocaru et al. 2006), but the most common method of VACNF 
growth is by PECVD using a catalyst on a substrate.  In this growth process, the catalyst 
can be patterned (layered, lined or spotted) on the substrate, and the substrate itself can be 
silicon (Merkulov et al. 2000), quartz (Chen and Dai 2001) or glass (Ren et al. 1998).  
The catalyst can be a variety of metals including, but not limited to, nickel, iron, cobalt 
and a number of alloys (Melechko et al. 2005).  Nickel (Ni) is a commonly used catalyst 
particle and can be patterned on the silicon (Si) wafer by photo- or electron beam 
lithography.  The size of the Ni dots can be determined, and at 100 nm in diameter and 40 
nm thick, the result is a single carbon nanofiber from each catalyst dot on the substrate 
(Melechko et al. 2005).  The spacing between each fiber can also be controlled, ranging 
from 2.5 to 20 µm pitch (pitch is defined as the distance between each nanofiber).  A 
carbon source is required for the nanofiber formation, typically in the form of a 
carbonaceous gas such as acetylene, and growth takes place at temperatures ranging from 
400 ºC to 1000 ºC.  More recently, nanofiber growth has been reported at temperatures as 
low as room temperature, using methane gas as a carbon source and resulting in 
“spaghetti-like” structures (Boskovic et al. 2002).  In these studies, the nanofiber growth 
took place at standard temperatures of 600-650 ºC.  The samples were pretreated with 
NH3 plasma to form a Ni catalyst nanoparticle and acetylene (C2H2) was introduced as 
the carbon source, instantly resulting in carbon nanofiber growth.  The length of the 
nanofibers is controlled by the length of plasma generation. 
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A number of VACNF applications can be found in the literature, including their use as an 
x-ray source (Matsumoto and Mimura 2003), a field-emission electron source (Baylor et 
al. 2004; Guillorn et al. 2001a; Guillorn et al. 2001b; Guillorn et al. 2004; Pirio et al. 
2002; Teo et al. 2003), nanoporous membranes (Fletcher et al. 2004; Hinds et al. 2004; 
Zhang et al. 2002), electrochemical probes (Fletcher et al. 2006a; McKnight et al. 2004a), 
atomic force microscopy tips (Ye et al. 2004) and charge storage devices (Chen et al. 
2001), site-specific biochemical functionalization (Fletcher et al. 2006b; McKnight et al. 
2006c), neuroelectrochemical probes in cells and tissue (McKnight et al. 2006a; Yu et al. 
2007a; Yu et al. 2007b) and intracellular gene delivery in eukaryotic cell types 
(McKnight et al. 2003b; McKnight et al. 2006b; McKnight et al. 2004b).  This review 
will look in further detail at the biologically relevant applications of VACNF arrays, 
including biochemical functionalization and intracellular gene delivery. 
 
Methods and Chemistry of Covalent DNA Immobilization 
 
The chemistry of functionalization and immobilization of DNA has been used for a 
number of applications including nucleic acid hybridization assays (Nikiforov and Rogers 
1995; Proudnikov et al. 1998; Wang et al. 1997), affinity chromatography (Bunemann 
1982; Macdougall et al. 1980; Mykoniatis 1985; Poonian et al. 1971), gene delivery (Cai 
et al. 2005a; McKnight et al. 2003b; McKnight et al. 2004b) and microscopic 
visualization (Allison et al. 1992; Morozov et al. 1996).  While some of these 
applications utilize noncovalent immobilization (Allison et al. 1992; Hirayama et al. 
1996; Shchepinov et al. 1994), covalent bonding between DNA and the substrate is the 
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most common immobilization method used.  Immobilization strategies resulting in 
covalent attachment of nucleic acids include biotin-streptavidin (Crucifix et al. 2004; 
Larsson et al. 2003; Su 2002), thiol-gold interaction (Ajore et al. 2007; Cho et al. 2004), 
UV-radiation (Kalachikov et al. 1992; Yamada et al. 2001; Yamada et al. 1999), 
cyanogen bromide activation (Poonian et al. 1971), disulfide-mercaptosilane (Rogers et 
al. 1999) and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) condensation (Ge 
et al. 2003; Mykoniatis 1985; Rasmussen et al. 1991).  Among other methods, EDC 
condensation has an advantage of forming an amide linkage without the addition of a 
spacer molecule (Grabarek and Gergely 1990).  This EDC-catalyzed approach has been 
effectively used for DNA immobilization on a variety of substrates in the past, including 
membranes (Okutucu and Telefoncu 2004), polymers (Taira and Yokoyama 2004; Taira 
and Yokoyama 2005), microwells (Rasmussen et al. 1991), glass slides (Zammatteo et al. 
2000), glass beads (Walsh et al. 2001), diamond films (Christiaens et al. 2006), gold 
electrodes (Ge et al. 2003), carbon electrodes (Millan and Mikkelson 1993), carbon 
nanotubes (Dwyer et al. 2002; Nguyen et al. 2002) and carbon nanofibers (McKnight et 
al. 2003a).  Due to the exposed graphene sheet edges at the surface, the functionality of 
VACNF arrays is highly advantageous.  Carbon nanofibers contain carboxyl groups 
(COOH) that can be used for the covalent attachment of primary amine groups (NH2) 
using EDC condensation.  For gene delivery in mammalian cells, plasmid DNA was 
tethered to VACNF arrays using the EDC-mediated condensation reaction between DNA 
base amines and carboxylic acid sites on nanofibers (McKnight et al. 2003a; McKnight et 
al. 2004b), and has also been used for immobilization of proteins (e.g., horseradish 
peroxidase) on VACNF arrays.  The carboxyl groups are nonexistent on the silicon 
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substrate of the VACNF array, and are often limited in their location on the nanofibers as 
well.  Sputtering of the silicon substrate onto the base of the nanofiber structure can 
eliminate accessible carboxyl groups in this region; likewise, the presence of a catalyst 
(e.g. nickel) at the tip of the nanofiber restricts carboxyl group availability.  However, the 
major portion of the nanofiber contains carboxyl groups that can be readily accessed by 
the primary amines present in three (adenine, guanine, cytosine) DNA bases.  This 
covalent interaction is catalyzed by the presence of EDC.   
 
In the EDC condensation, the EDC molecule reacts with a proton to form a carbocation.  
The carbocation subsequently reacts with an ionized carboxyl group on the carbon 
nanofiber to form the highly reactive O-acylisourea derivative.  O-acylisourea becomes 
reprotonated at the site of Schiff base and reacts again with an ionized carboxyl group to 
produce carboxylic anhydride which will rapidly form an amide bond in the presence of 
exposed primary amine groups in the DNA sequence.  The ultimate product is a covalent 
linkage via a peptide bond between the DNA and the carbon nanofiber (Figure 1). 
 
While the EDC-catalyzed reaction is easy applicable and straightforward for DNA binding 
strategies, a number of factors can affect the efficiency of the covalent immobilization and 
the functionality of the DNA after immobilization.  N-acylurea is a product of the reaction 
between carboxylic acids and carbodiimides if the primary amines are not present or excess 
carbodiimide is present.  In the presence of excess carbodiimide, the formation of N-
acylurea from the O-acylisourea derivative can inhibit the production of amide linkages 
even upon addition of amines to the reaction (Nakajima and Ikada 1995). 
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Figure 1.  EDC Condensation of DNA on a carbon nanofiber.  In this reaction, the 
EDC molecule reacts with a proton to form a carbocation.  The carbocation subsequently 
reacts with an ionized carboxyl group on the carbon nanofiber to form a highly reactive 
ester intermediate that is an O-acylisourea derivative.  The active ester intermediate 
becomes reprotonated at the site of Schiff base and reacts again with an ionized carboxyl 
group to produce carboxylic anhydride which will rapidly form an amide linkage in the 
presence of exposed primary amine groups in the DNA sequence.  The ultimate product 
is a covalent linkage via a peptide bond between the DNA and the carbon nanofiber. 
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Therefore, it is important to refrain from using excessive amounts of EDC in the reaction.  
The EDC reactivity with carboxyl groups is highly dependent on pH, with an optimum 
pH between 3.5 and 4.5 for short incubation times (Nakajima and Ikada 1995).  EDC is 
highly stable at neutral to higher pH levels (pH 4 – pH 8) for up to 5 hours at 25 ºC.  
However, very little carbodiimide activity remained after 2 hours at pH levels below 4 
(Nakajima and Ikada 1995).  Additionally, the presence of free amines, sulfhydryls or 
carboxyl groups in the buffer can compete with bond formation, rendering the DNA 
immobilization incapacitated (Hermanson et al. 1992).  A well-characterized buffer like 
2-(N-morpholino)ethanesulfonic acid (MES) buffer with pH 4.5 is often used 
(Hermanson et al. 1992).  For biological applications such as gene delivery of 
immobilized DNA, it is also important to limit the incubation time in acidic buffers, due 
to potential degradation of DNA.  Millan demonstrated that when using EDC for DNA 
immobilization to carbon, the amide bond is formed specifically at exposed guanine and 
cytosine amines (Millan et al. 1992).  Since DNA bound to carboxyl groups at these 
binding sites cannot be effectively directed, binding may occur at undesirable locations 
within transcriptional regions of the DNA sequence and render the tethered DNA 
template transcriptionally-inactive.  Binding within the coding sequence may also 
interfere with reading and complementation of the base during mRNA elongation.  
Schaffer et al. found that the disassociation of noncovalent interactions between 
polycations and DNA was required for efficient expression of the DNA by transcriptional 
machinery (Schaffer et al. 2000).  Thus, the transcriptional activity of template can be 
significantly reduced, if not completely hindered by the interaction of the template with 
large, covalently-bound molecules.  Therefore, tethered gene strategies, where solid 
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scaffolding can present even larger hindrances, may present an additional variable with 
respect to evaluation of efficiency (i.e. transgene expression per unit DNA).   
 
Electrochemistry measurements have suggested that carbon nanofibers have a rough, 
uneven surface.  Although a non-geometric surface can create complications for 
estimations of total surface area, electrochemistry measurements demonstrate that on 
average the surface area of a carbon nanofiber mirrors its vertical height (e.g., a nanofiber 
with a vertical height of 15 µm has a surface area of 15 µm2).  Moreover, the percentage 
of total surface area of carbon nanofibers on a VACNF array chip is dependant on the 
pitch of the carbon nanofibers.  For instance, a VACNF chip containing 15 µm 
nanofibers at a 5 µm pitch has a total surface area per unit fiber of 40 µm2, of which the 
carbon nanofibers make up 15 µm2, or 37.5% of the total surface area.  The respective 
surface area of the nanofiber decreases to 13% if the pitch is increased to 10 µm between 
each nanofiber.  These percentages of the total surface area are a rough estimate, due to 
fluctuations in actual surface area of the carbon nanofiber and fluctuations in nanofiber  
height during growth in the PE-CVD process.  In addition, predictions of DNA 
adsorption on the surface of a VACNF chip become increasingly complicated, due to 
differences in surface chemistry and potential preferential adsorption to either the carbon 
nanofiber or silicon substrate.  For example, if 100 ng of DNA was allowed to dry on the 
VACNF chip described above, while the carbon nanofibers compose 37.5% of the total 
surface area, more or less than 37.5% of the DNA may be initially adsorbed onto the 
carbon nanofiber surface.  Likewise, only a portion of the adsorbed DNA may be 
transcriptionally active after the drying process.  Therefore, precise theoretical 
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calculations of the percentage of DNA that is initially adsorbed to a VACNF chip and 
remains transcriptionally available to the cell are difficult to estimate without direct 
experimentation.  It would be helpful for future applications of gene delivery to know 
how much DNA remains transcriptionally active after EDC-condensation immobilization 
on the VACNF arrays.  
 
Traditional Methods of Gene Delivery in Mammalian Cells 
 
Transfection is the process of introducing foreign DNA into eukaryotic cells and is often 
simply referred to as gene delivery in mammalian systems.  Many different methods of 
transfection have become staples in the field of biological studies in the last few decades.  
While some cell types exhibit the natural uptake of foreign DNA under certain 
circumstances (Kidwell 1993; Lehmann and Sczakiel 2005; Nevoigt et al. 2000), 
methods of transfection typically include some means of shielding the foreign DNA from 
cellular recognition and degradation, or evading the degradation pathways altogether.  
Mammalian transfection can result in transient or stable expression.  Transient expression 
refers to short-term gene expression and protein production of the introduced foreign 
DNA that typically peaks between 12 and 72 hours (Colosimo et al. 2000), but on some 
occasions can last up to 10 days post-transfection (Baldi et al. 2007).  Genes that are 
transiently expressed are not incorporated into the genome of the host cell, and 
expression occurs in the absence of a selection agent (i.e. blasticidin-S).  This results in 
the loss of the introduced gene upon cell division.  Transient expression assays are 
helpful for some applications, including recombinant protein production in large-scale 
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batch cultures for pharmaceuticals (Geisse and Henke 2005; Meissner et al. 2001; Shi et 
al. 2005).  However, for the majority of applications, it is advantageous to have a stably-
inserted copy of the gene internal to the host chromosomal DNA.  This requires stable 
transfection of cells.  Stable transfection occurs when the foreign gene is stably inserted 
into the host cell chromosome via recombination.  Using microinjection in CHO-K1 
cells, as high as 10% of the cells have been observed to insert foreign DNA by 
nonhomologous recombination when multiple copies are introduced into the nucleus 
(Proctor 1992a).  In order to resolve which cells have inserted the foreign gene into the 
chromosome during transfection, the gene of interest must be coupled with a selection 
agent.  The selection agent typically imparts antibiotic resistance to the cell, allowing the 
cells possessing the gene of interest to survive after the addition of antibiotics to the cell 
culture medium.  While stable transfection of mammalian cells gives the ability to 
perform long-term investigations on cell lines that are all genotypically identical, this 
method has the disadvantage of being costly and time consuming; it could easily take 2-3 
weeks for the generation of a stable mammalian cell line, and often requires a number of 
months (Colosimo et al. 2000). 
 
Mammalian transfection can be organized into three categories:  chemical, electrical and 
physical.  Chemical methods of transfection include, but are not limited to, calcium 
phosphate mediated (Graham and van der Eb 1973), DEAE-dextran mediated (Pagano 
and Vaheri 1965), peptide mediated (Wagner et al. 1992), dendrimer-mediated 
(Kukowska-Latallo et al. 1996), liposome based (Felgner et al. 1987), and 
polyethyleneimene based techniques (Ferrari et al. 1997).  Electrical means of 
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transfection are limited to electroporation (Andreason and Evans 1988) and sonic-
poration using ultrasound energy (Unger et al. 1997).  However, chemical and electrical 
methods will not be addressed in this review.  The physical transfection methods of 
microinjection and particle bombardment are the most similar methods to impalefection 
and will be discussed in further detail. 
 
Microinjection is one of the most versatile means of gene delivery to living cells.  
Microinjection is a variation of conventional needle injection but differs in that it uses 
ultrafine micropipets for the delivery of nucleic acids to a specific intracellular location.  
Microinjection has been used for DNA delivery to various embryos (Guille 1999; Xu 
1999), oocytes (Jaffe and Terasaki 2004), eggs (Cheers and Ettensohn 2004), bacteria 
(Knoblauch et al. 1999), cultured cells (Graessmann and Graessmann 1983), and specific 
organelles (Kagawa et al. 2001).  In fact, nearly any mammalian cell type can be 
successfully transfected using this method (Proctor 1992a).  In microinjection, efficiency 
levels (the number of transgenic colonies generated per transfected cell) and expression 
levels of the DNA are extremely high (Proctor 1992a).  When microinjection in the 
nucleus was compared with injection into the cytoplasm, the levels of gene expression in 
the nucleus were significantly higher (Capecchi 1980).  Another advantage is that the 
number of gene copies can be discretely controlled and delivered to specific individual 
cells (Mueller et al. 1980).  The disadvantage with this method is its laborious nature; 
only one cell can be injected at a time and multiple injections are often needed before a 
successful transfection takes place (Luo and Saltzman 2000). 
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Biolistic bombardment (also termed ballistic bombardment or particle bombardment) is 
another physical transfection method similar to impalefection.  While biolistic processes 
of transformation are relatively new, they have been commonly used for plant cells 
(Sanford et al. 1987), bacteria (Shark et al. 1991), fungi (Armaleo et al. 1990), animal 
tissues (Yoshida et al. 1997), and mammalian cell cultures (Heiser 1994; Yang et al. 
1990; Zelenin et al. 1989).   Biolistic bombardment consists of delivering DNA internally 
to the target cell by coupling it with biocompatible accelerated particles such as gold or 
tungsten (Heiser 2004).  Particles are accelerated by pressurized gas, and calibration of 
the gas pressure can determine the optimal level for individual cell types.  Advantages of 
using biolistic bombardment include the bypass of specific membrane requirements for 
DNA uptake, the low level of DNA required (submicrogram quantities), the delivery to 
multiple cells simultaneously, and the in vivo application of transfection 
(Muangmoonchai et al. 2002; Tanigawa et al. 2002).  The disadvantages of using biolistic 
bombardment include the high level of manipulation involved and the expensive cost of 
devices (gene gun) and reagents (gold particles) (Heiser 2004).   
 
Impalefection:  Vertically Aligned Carbon Nanofiber-Mediated Gene Delivery 
 
The process of intracellular gene delivery to eukaryotic cells using VACNF arrays is 
referred to as impalefection (McKnight et al. 2004b).  The term impalefection refers to 
the mammalian cells being transfected with DNA due to physical impalement with 
nanofibers.  The success of impalefection can primarily be attributed to the physical and 
chemical properties of the VACNF.  The nanoscale tip of the fiber (10-100 nm) 
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contributes to the impalement of the cell membrane and/or cell wall, and can be 
compared to the use of ultrafine micropipets that have been used in microinjection for 
DNA delivery since the early 1970s (Jaenisch and Mintz 1974; Lin 1971).  Another 
attractive feature of the VACNF is its robust flexibility.  While the tensile strength of 
carbon nanofibers is 100 times less than that of single-walled carbon nanotubes (Callister 
2003; Hughes 1987), nanofibers have shown high levels of resilience during the 
impalefection process.  It has been demonstrated that VACNFs are strong enough to 
penetrate the rigid structure of plant and yeast cell walls (McKnight et al. 2006b).  
Further, the nanoscale diameter of VACNFs allows the plasma membrane of mammalian 
cells or the cell wall of plant cells to recover following nanofiber penetration, enabling 
the recovery and proliferation of the interfaced cell.  This recovery includes the resealing 
of the membrane, which has been observed using propidium iodide.  Immediately after 
impalefection, a large portion of mammalian cells were stained with propidium iodide, 
while mammalian cells in the presence of propidium iodide five minutes after 
impalefection were not stained (data not shown).  This demonstrates that the membrane is 
impaled during impalefection, and successfully and rapidly reseals, either around the 
nanofiber or in the absence of the nanofiber.   
 
VACNFs are also richly populated with chemical handles for post-synthesis modification 
of the nanofiber surface.  Functional groups on the surface of the nanofiber can be 
adsorbed or covalently attached with a variety of macromolecules (i.e. plasmid DNA and 
soybean peroxidase) using simple chemistry techniques including 1-ethyl-3-(3-
dimethylaminopropylcarbodiimide) (EDC) condensation or biotin-streptavidin binding 
 26
strategies (Fletcher et al. 2006b; McKnight et al. 2003b; McKnight et al. 2006c).  
Following this immobilization process, at least some of the molecular species retain their 
transcriptional and/or enzymatic activity.  However, the percentage and amount of active 
species remains unknown. 
 
Impalefection was first demonstrated by McKnight et al. (McKnight et al. 2003b).  In this 
seminal work, VACNFs were adsorbed or covalently immobilized with plasmid DNA 
and subsequently used as a platform for parallel DNA delivery and expression monitoring 
of the green fluorescent protein (gfp) gene in Chinese Hamster Ovary (CHO-K1) cells.  
The protocol for this procedure is very straightforward:  DNA is coated on the surface of 
the nanofibers and introduced to the cells by pressing the nanofibers into a settled cell 
suspension fluid from freshly passed CHO-K1 cultured cells.  Once impaled on the 
nanofiber platform, the cells are then placed in fresh medium and allowed to recovery at 
37 ºC and 5% CO2.  More recent studies have determined that plasmid DNA encoding for 
the gfp gene attached to the nanofiber can be stably inserted into the genome, resulting in 
a colony of GFP-expressing cells.  However, some impalefected cells receive and express 
the DNA on the nanofiber, but do not pass it on to their progeny (McKnight et al. 2003b; 
McKnight et al. 2004b).  This could be a result of the DNA being immobilized on the 
carbon nanofiber and residing in the nucleus of the cell where it can be transcribed 
without difficulty, but not passed on to the daughter cells.  This is more often observed 
after EDC-mediated immobilization of DNA on the nanofibers.  Spatially indexed 
VACNF arrays can also be used for convenient location and tracking of individually 
expressing cells without constant analysis under a microscope (McKnight et al. 2004b). 
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While the time allowed for recovery after impalefection is typically 18-24 hours, 
transgene expression has been observed as early as 75 minutes after impalement (data not 
shown).  In other methods of transfection, a minimum of 24 hours is usually required for 
recovery and expression.  This significantly rapid lag time for gene expression could be 
ascribed to the direct penetration and introduction of DNA to the nucleus, thus being 
limited strictly by the amount of time required for transcription of the gene and 
translation of the resulting mRNA transcript into protein.  Direct nuclear penetration has 
been implied in the impalefection process by a number of observations.  Along with the 
rapid gene expression after impalement, nuclear impalement has been experimentally 
observed using a nuclear isolation method described by Butler (Butler 1984).  Using this 
method, CHO-K1 cells were impalefected on a VACNF array platform, and all cellular 
components excluding the nuclei were lysed.  Samples were then fixed and viewed under 
SEM.  Nuclei were frequently observed with nanofibers inserted in them, suggesting that 
not only are impaled cells often recovering and remaining on the nanofibers themselves, 
but nuclei are also directly impaled during the process (data not shown).  Direct cellular 
impalement has also been observed using confocal microscopy.  Frequent impalement of 
the nucleus in CHO-K1 cells may be due to the large volume of the nucleus inside this 
cell type.  Rounded cells have a diameter of 10-15 µm, while the nucleus of each cell can 
be from 5-10 µm inside the cell.  This makes the nucleus a large target during 
impalefection, and highly likely to be penetrated.  While this is the case, not all 
impalefected cells remain penetrated on the nanofiber.  Their ability to express DNA is 
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probably similar to the uptake and expression of DNA after the “scrape-loading” 
transfection method (Fechheimer et al. 1987; McNeil et al. 1984). 
 
The efficiency of transfection and frequency of transgene expression following 
impalefection have not been investigated.  While the efficiency does not likely match the 
high levels of efficiency of other transfection methods, there are a number of advantages 
to the VACNF-mediated gene delivery method.  First, expression of the delivered DNA 
can take place very rapidly, due to the penetrant nanofiber and delivered DNA residing 
directly in the nucleus.  This bypasses the need for internalization of the DNA, evasion of 
potential cytosolic degradation, localization of the DNA to the nuclear membrane, 
decomplexation of the DNA from its carrier and facilitation of nuclear import, some or 
all of which must occur prior to the initiation of transcription in other commonly used 
transfection methods (Lechardeur and Lukacs 2006).  Secondly, the immobilization of 
DNA on the surface of the nanofiber using EDC condensation and other tethering 
strategies allows for potential control over the fate of introduced genes.  This could be 
highly advantageous for environmental applications, where genetic manipulation of 
species and cell types and control over these transgenic variants for in situ studies is 
extremely desirable.  Also, the spatially indexed feature of VACNF platforms allows for 
convenient location and tracking of a multitude of individual cells over extended periods 
of time without the need for expensive equipment.  Traditionally, this would require a 
microscope capable of CO2 and temperature regulation and an additional tracking system 
to monitor more than an individual cell per experiment.  Using VACNF arrays, no 
external equipment is required and cells can simply be transported from the incubator to 
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the microscope time and time again.  Another advantage of impalefection is that the 
simplicity of how the method works makes it potentially applicable to a number of cell 
types, including hard-to-transfect cell types such as neuronal cell lines and plant cells. 
 
While the impalefection method is very straightforward and simple, there has been some 
degree of irreproducibility in the past.  The cause of this variability has been difficult to 
identify, and warrants a need to identify and optimize the specific parameters of the 
impalefection method in order to gain consistent and reproducible results for future 
experiments.  Optimization of physical transfection methods can involve a number of 
parameters.  In microinjection, the manufacture of pipets, DNA concentration, viscosity 
and size of the target cell must all be taken into account (Brown and Fleming 1986; 
Colosimo et al. 2000).  No data has been collected on the importance of cell age and 
physiology, although it can be assumed that metabolic activity is an important factor for 
membrane recovery following the injection of DNA.  In biolistic bombardment, gas 
pressure, target distance, DNA concentration, particle size and particle density are the 
main parameters involved in method optimization (Colosimo et al. 2000; Heiser 1994).  
Sanford et al. have an extensive review on optimization of biolistic bombardment, noting 
that cell age and physiology can vary greatly depending on the organism or cell type 
(Sanford et al. 1993).  In B. megaterium strain 7A17, the highest efficiency was observed 
with cells transformed in early-log phase (Shark et al. 1991).  In E. coli JA221 there 
appears to be no difference between midlog, late-log or stationary phase growth of cells 
for transformation efficiency (Smith et al. 1992).  For biolistic bombardment in 
Saccharomyces cerevisiae, the optimal efficiency of transformation occurs in mid-
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stationary phase (Armaleo et al. 1990).  Likewise, optimal growth phase of plant cell 
suspensions for transformation can differ greatly from species to species.  In tobacco NT1 
cells, 4 days after subculturing (early log-phase) results in the highest transformation 
efficiency (Paszty and Lurquin 1987).  However, in Oryza sativa L. Japonica cv. Taipei 
309 rice cells, the most efficient method is to use cells 6-weeks after subculturing 
(stationary phase) (Chen et al. 1998).  There are no data available on the optimization of 
mammalian cell physiology for biolistic bombardment of cell cultures.  Conversely, a 
number of studies have had success to varying degrees with biolistic transformation in 
different mammalian cell lines.  Novakovic et al. used biolistic bombardment in B-16 
melanoma cells, breast adenocarcinoma MCF7 cells, and normal fibroblast L929 cells 
(Novakovic et al. 1999).  In this study, cells were cultured to high density before 
bombardment.  The proportion of transfected cells were 1%-38% in B-16 cells, 2%-27% 
in MCF7 cells, and 1%-11% in L929 cells.  O’Brien and Lummis had similar transfection 
efficiency (up to 30%) in HEK293 cells when grown to 60%-80% confluency prior to 
bombardment (O'Brien and Lummis 2004).  For neuronal cell lines or astrocytes, 
McAllister suggests transfecting cells near confluency, although this is an ambiguous 
description (McAllister 2000).  However, the expected transfection efficiency for random 
physical methods like biolistic bombardment is typically low in neuronal cells, and are 
often administered to slice preparations or disassociated cells as opposed to adhered 
cultured cells (McAllister 2000).  These studies demonstrate that cell physiology can play 
a large role in measuring the efficiency and optimization of physical transfection 
methods.  Physiological factors of mammalian cells need to be further addressed in 
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relation to the efficiency of impalefection.  These include cell concentration, cell 
confluency, cell type and culturing conditions. 
 
Potential Mammalian Cell Responses to Impalefection 
 
After DNA is delivered to mammalian cells using VACNF arrays, the cells recover from 
the nanofiber impalement and the transgene is expressed.  So the question remains: How 
do the internalized nanofibers affect the transcriptional activity of the cell?  How do the 
cells recover in response to nanofiber impalement and which gene pathways are up-
regulated to achieve this response?  How does the membrane reseal after nanofiber 
impalement?  Investigations are currently underway in order to answer these questions 
more directly, and insight on mammalian cell membrane repair can be found in the 
literature.  While the cellular response and genetic pathways of cell recovery after 
nanofiber impalement will not be addressed in this study, understanding the potential 
physiological response of the cell to intracellular nanofiber penetration is crucial in our 
efforts to characterize and optimize the impalefection method in mammalian cells. 
 
There are a number of observed effects in mammalian cells in response to acute cell 
membrane injury.  This infiltration of the cellular membrane can be achieved using fluid 
sheer stress, scrape-induced damage or laser irradiation (McNeil et al. 2006; Mellgren et 
al. 2007; Miyake et al. 2002; Ranjan et al. 1996).  These methods result in membrane 
disruptions between 1 and 1000 µm2 (McNeil and Terasaki 2001; Steinhardt et al. 1994), 
somewhat larger than the size of disruption that a 100 nm diameter VACNF would leave 
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in the cell membrane.  However, the cellular processes involved may be very similar.  An 
increase in glucose uptake is involved in repair of membrane integrity, most likely due to 
an increase in energy requirements  (Ikari et al. 2003).  It is well established that the 
resealing of membranes requires the influx of extracellular Ca2+ into the cell (McNeil and 
Steinhardt 2003).  However nucleated mammalian cells can reseal holes < 1 µm in the 
absence of Ca2+ (McNeil and Kirchhausen 2005).  For larger holes, Ca2+ influx to the cell 
triggers the fusion of vesicles and the recruitment of vesicle-vesicle aggregates to the 
damaged site, resulting in a “patch” of the membrane (McNeil 2002; McNeil et al. 2001; 
McNeil et al. 2003; Miyake and McNeil 2003).  While it was originally thought that 
lysosomes were the vesicular candidates for membrane sealing , it has recently been 
demonstrated that when lysosomal fusion is inhibited by vacuolin 1, the cellular 
membrane can still be repaired as normal (Cerny et al. 2004).  This has lead to a hunt for 
a new repair organelle candidate within the cell, with enlargeosomes being the current 
focus (McNeil and Kirchhausen 2005).  While these cellular processes have been 
characterized, membrane recovery on a molecular scale is less understood.  The family of 
SNARE proteins has been linked with a number of roles in membrane fusion (Rothman 
2002).  The family of synaptotagmin proteins are also involved in Ca2+-mediated vesicle 
fusion at the membrane surface, and inhibition of synaptotagmin III and synaptotagmin 
VII results in a lack of membrane resealing in fibroblasts (Reddy et al. 2001).  Fluid shear 
stress on the cellular membrane of Chinese hamster ovary cells has been shown to induce 
the expression of c-fos, a transcriptional activator involved in growth, differentiation and 
stress (Ranjan et al. 1996).  Annexin A1, a cytosolic protein that binds to phospholipids 
and increases aggregation and fusion of lipid bilayers, is recruited to the torn plasma 
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membrane after HeLa cells are scrape damaged (McNeil et al. 2006).  This implies that 
annexin A1 also plays a role in membrane repair machinery.  More recently, calpains 
have been associated with calcium-dependent membrane repair (Mellgren et al. 2007).  
Calpains are cysteine proteinases found in all animal cells that target cytoskeletal proteins 
for proteolysis (Dayton et al. 1976; Wang and Yuen 1999).  This suggests that 
cytoskeletal remodeling is immediately induced to assist in membrane repair.   
 
Inducible Gene Silencing and the RNA Interference Pathway 
 
It has been demonstrated that VACNF arrays can be used as electrodes for induction and 
recording of electrochemical signals of mammalian cells (McKnight et al. 2006a; Yu et 
al. 2007b), and it has additionally been demonstrated that VACNF arrays can be used for 
gene delivery and the covalent immobilization of genes on the nanofiber surface 
(McKnight et al. 2003b; McKnight et al. 2004b).  At this point, it can be asked what the 
limits of VACNF arrays may be for cellular gene expression and phenotypic response.  
As an electrochemical probe that can stimulate cellular responses and is often residing 
inside the nucleus of the cell, there is the potential that a resident nanofiber may 
ultimately be used to electronically modulate the transcriptionally activity of DNA within 
the nucleus, thus controlling gene expression or lack thereof.  While the parameters 
involved in achieving this function are still under investigation and this specific 
application is out of reach at this point, steps can be taken towards this goal.  One directly 
addressable issue is whether endogenous genes within the cellular genome can be 
controlled from the VACNF platform.  Due to recent advances in molecular biology and 
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the discovery and exploitation of the RNA interference pathway, endogenous genes can 
be silenced within a cell exogenously using post-transcriptional gene-silencing 
technology.  These processes are discussed in more detail below. 
 
RNA interference (RNAi) is an evolutionarily conserved cellular process that operates to 
silence gene expression by the specific targeting of mRNA for degradation.  While the 
mechanism of RNAi-mediated silencing was first described in Caenorhabditis elegans 
(Fire et al. 1998a), the initial effects of RNAi were observed in the early 1990s in 
transgenic petunias (Napoli et al. 1990; van der Krol et al. 1990).  The RNAi pathway has 
now been identified in most eukaryotic organisms including, but not limited to 
Trypanosoma (Shi et al. 2000), Drosophila (Svoboda et al. 2000), Arabidopsis (An et al. 
2003), Entamoeba (Kaur and Lohia 2004), yeast (Sigova et al. 2004) and humans 
(Elbashir et al. 2001).  In the RNAi pathway, long double-stranded RNAs (dsRNAs)  are 
recognized by the RNase III enzyme Dicer which cleaves the dsRNAs into small 
interfering RNAs (siRNAs) that range from ~21 to 24 base pairs in length (Bernstein et 
al. 2001a).  These siRNAs are subsequently joined by the RNA-induced silencing 
complex (RISC) and bind directly to the complementary mRNA transcript, resulting in 
cleavage and degradation of complementary mRNA transcripts (Hammond et al. 2000).  
This targeting of mRNA for degradation and inhibition of translation is referred to as 
post-transcriptional gene silencing (PTGS) or co-suppression (Zamore et al. 2000).  
While the major function of RNAi seems to be as a viral defense mechanism (Dalmay et 
al. 2001; Mourrain et al. 2000), it has been proposed that siRNAs are also used to silence 
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transposable elements and repetitive genes to help stabilize the genome (Novina and 
Sharp 2004; Volpe et al. 2002).   
 
The RNAi pathway has additionally been utilized as a therapeutic approach against 
human diseases (Kim and Rossi 2007), including age-related macular degeneration 
(Check 2005; McFarland et al. 2004) and respiratory syncitial virus (RSV) infection.  
Clinical trials are currently underway for other therapies which target viral diseases 
(Dykxhoorn and Lieberman 2006), neurodegenerative disorders (Raoul et al. 2006) and 
cancer (Pai et al. 2006), and exciting recent advances have been confirmed in preventing 
HIV-1 infection (Bagasra 2005; Jacque et al. 2002; Rossi 2006), although the safety of 
these therapies are possibly in question (Couzin 2006).  The molecular mechanism of 
RNAi has also been used for studying gene expression and gene function in mammalian 
cells.  Highly specific and potent siRNAs have been repeatedly incorporated into 
methodologies for genetic studies (Brummelkamp et al. 2002; Kasim et al. 2004; Kaykas 
and Moon 2004; Mangeot et al. 2004; Matsukura et al. 2003a; Paddison et al. 2004).  In 
Caenorhabditis elegans, dsRNA has been introduced in a variety of ways (Fire et al. 
1998a; Kennedy et al. 2004; Lau et al. 2001), and gene screening has been performed on 
a large scale (Berns et al. 2004; Konig et al. 2007; Maeda et al. 2001).  The synthesis of 
short dsRNAs has opened the door for methodologies in reverse genetic studies of 
mammalian cells that only formerly existed for nematode and fruit fly platforms 
(Matsukura et al. 2003a).  In mammalian cells, the injection of long dsRNAs directly into 
mammalian cells can result in a cytotoxic reaction by triggering a type-I interferon 
response and terminating genome-wide translation (de Veer et al. 2005; Manche et al. 
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1992).  However, introducing siRNAs directly to mammalian cells can bypass the 
induction of a cytotoxic response, resulting in efficient silencing of the target genes 
(Kariko et al. 2004; Kim et al. 2004).  Likewise, vectors of DNA expressing siRNA 
sequences as short inverted repeats (or short hairpin RNAs, also shRNAs) have been 
developed and validated for stable down-regulation of targeted gene expression 
(Brummelkamp et al. 2002; Kasim et al. 2004; Kaykas and Moon 2004; Mangeot et al. 
2004; Matsukura et al. 2003a; Paddison et al. 2004).  In mammalian cells, these shRNA 
vectors include designs for constitutive and inducible gene silencing (Bantounas et al. 
2004; Fewell and Schmitt 2006).  The conditional gene silencing vectors can be induced 
by a number of compounds (Wiznerowicz et al. 2006), but tetracycline or doxycycline (a 
tetracycline derivative) induction are the most common choices in the literature (Ito et al. 
2006; Kappel et al. 2007; Lin et al. 2004; Matsukura et al. 2003a).  Polymerase III 
promoters are highly advantageous for inducible shRNA vectors due to their high level of 
activity (approximately 4 x 105 transcripts per cell), lack of a polyadenosine tail and well-
defined transcriptional start sites (Brummelkamp et al. 2002; Matthess et al. 2005).  
These include the uridine-rich U6 and histone 1 (H1) gene promoters, which have both 
been altered to contain two Tet operator (tetO2) sites in shRNA vectors (Wiznerowicz et 
al. 2006).  In tetracycline inducible expression, these TetO2 sites bind the tetracycline 
repressor protein (TetR), which results in repression of transcription of downstream 
shRNA sequences.  However, upon the addition of tetracycline (Tc), Tc binds tightly to 
TetR, generating a conformational change that displaces TetR from tetO2 sites (Gossen 
and Bujard 2002; Ramos et al. 2005).  With TetR sequestered, the H1 promoter is no 
longer sterically hindered, resulting in transcription of the shRNA sequence. This results 
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in generation of “induced” siRNAs that can specifically silence a targeted gene.  The 
simple concept and ease of use in RNAi technology makes it a very attractive and 
powerful tool in genetic studies when compared to traditional methods (e.g. knockout 
mice). 
 
OBJECTIVES OF THIS STUDY 
 
The major goals of this study were to experimentally investigate a series of hypotheses 
which have been chosen to further characterize the process of VACNF-mediated 
impalefection and evaluate the transcriptional activity of EDC-immobilized DNA on the 
VACNF arrays.  Lastly, impalefection was used for studying inducible gene silencing to 
test the range and applicability of the method for analyzing intracellular control and 




I. The parameters of impalefection can be characterized and the process of 
impalefection can be optimized for higher efficiency of gene expression after 
cellular impalement in Chinese hamster ovary cells. 
II. DNA immobilized on VACNF arrays by EDC-condensation remains 
transcriptionally active and can be quantified. 
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III. The transcription of impalefection-delivered DNA can be induced in Chinese 
hamster ovary cells on VACNF arrays and can subsequently control the 








OPTIMIZATION OF THE VERTICALLY-ALIGNED CARBON NANOFIBER-






The ability to insert a foreign gene into a mammalian cell line of choice is a pivotal tool 
in the current age of molecular biology.  A variety of more traditional transfection 
methods, including chemical, electrical, physical and mechanical means, have become 
essential laboratory procedure for the generation of transient cell assays and stable-
chromosomal insertions.  More recently, nanostructured architectures have shown 
promise in bringing new application to the conventional discipline of mechanical 
transfection.  These nanosized structures include nanofibers (McKnight et al. 2003b; 
McKnight et al. 2004b), nanotubes (Cai et al. 2005b; Pantarotto et al. 2004), nanorods 
(Salem et al. 2003), nanoparticles (Bauer et al. 2004; Chowdhury et al. 2006; Zhi et al. 
2006) and nanoscaffolds (Uchimura et al. 2007).  Multifunctional nanorods and 
nanoparticles offer a novel approach because they can be coupled with condensed DNA, 
and can also be incorporated with ligands for specifically targeted sites of delivery 
(Green et al. 2007; Salem et al. 2003; Tan et al. 2007).  Likewise, vertically aligned 
carbon nanofiber (VACNF) arrays possess unique characteristics for gene delivery in 
mammalian cells.  In a process termed impalefection, stacked-funnel type carbon 
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nanofibers of micron lengths and nanometer tips which have been deterministically 
synthesized in a vertical fashion on a silicon substrate using plasma-enhanced chemical 
vapor deposition (PECVD) are used as a platform to physically impale mammalian cells 
(McKnight et al. 2004b).  These nanofibers can be spotted or covalently immobilized 
with transcriptionally-active plasmid DNA containing the gene of interest and allow for 
parallel gene delivery into hundreds of mammalian cells (Mann et al. 2007; McKnight et 
al. 2003b).  Mammalian cells can then recover from the impalefection process and 
proliferate on the nanofiber substrate, allowing for cell expression assays over extended 
periods of time.  Utilizing spatial indexing of the VACNF arrays, individual cells can be 
tracked over time without having to remain under constant observation (McKnight et al. 
2004b).  This advantage allows the VACNF chips and impalefected cells to be monitored 
in a relatively simple and inexpensive manner, due to the cells remaining under and 
returning to the preferred conditions in the incubator except for times of analysis.   
 
While the method of impalefection on VACNF arrays has been successfully used for 
gene delivery and subsequent experimentation, the process itself has never been 
optimized.  The efficiency of gene delivery and expression of marker genes in cells using 
impalefection is often as high as 70%-80% in some regions of nanofiber array chips, 
while at other times no transfected cells have been observed.  This level of variability can 
be seen in similar mechanical transfection methods, such as biolistic bombardment and 
microinjection.  In his excellent review, Proctor states that microinjection “…is the least 
efficient method that has been used to transfer DNA into mammalian cells …. [and] is 
also the most technically difficult” (Proctor 1992b).  However, these methods, along with 
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impalefection, are of great use due to their specialized applications.  The difficulty and 
variability of mechanical transfection methods are largely in part from the numerous 
steps and components in the process.  Therefore, like other mechanical transfection 
methods, it is vital to optimize the parameters involved in impalefection using VACNFs 
in order to gain consistent and reproducible results for future experiments.   
 
Efficiency of impalefection is defined as the number of cells expressing the delivered 
gene of interest divided by the total number of viable cells after impalement.  The 
parameters that can potentially affect the efficiency of impalefection are seemingly 
unlimited.  Some mechanical parameters such as nanofiber length and tip diameter are 
easy to control during nanofiber synthesis.  However, the effects of other parameters such 
as the cellular membrane composition are harder to evaluate, but nonetheless affect the 
efficiency to a similar degree.  In this study, the method of impalefection was optimized 
by evaluating predetermined mechanical, chemical and biological parameters.  A list of 
these impalefection parameters can be seen in Table 1.  In order to measure efficiency 
consistently, the pd2EFYP-N1 vector, containing the gene sequence encoding for the 
enhanced yellow fluorescent protein (YFP) was introduced to a cyan fluorescent protein 
(CFP) stably-expressing cell line or wild type cell line.  The dual marker gene system was 
used for ease of cell counting and monitoring positive cell impalefections among non-
impalefected cells using an inverted fluorescent microscope.  Afterwards, the efficiency 
of the optimized technique was compared to the efficiency of impalefection prior to 
optimization. 
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Table 1.  Different parameters of the impalefection method. 
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Materials and Methods 
 
Plasmid isolation and maintenance 
 
Plasmids were maintained in E. coli strain JM109 and stored at -80º C.  E. coli strain 
JM109 was grown in Luria-Bertani (LB) broth at 37° C with or without 100 µg 
ampicillin/ml or 50 µg kanamycin/ml, depending on the requirements for plasmid 
maintenance.  Plasmid isolation was performed using Wizard mini- or midi-prep kits 
(Promega, Madison, WI).  The expression vectors pd2EYFP-N1 containing yellow 
fluorescent protein (YFP) and pd2ECFP-N1 containing cyan fluorescent protein (CFP) 
were purchased from Clontech (Mountain View, CA).   
 
Cell culture and reagents 
 
All cell types were maintained in plastic T25 and T75 flasks under 5 % CO2 and 95 % 
humidified air at 37º C.  The cell types used are as follows:  Chinese hamster ovary 
(CHO-K1), human epithelial kidney (HEK293), human colorectal (HCT-116), rat liver 
epithelial (Clone 9), rat adrenal gland (PC12), rat aorta (A10) and mouse 
monocyte/macrophage (J774) cells.  CHO-K1-CFP cells are a subclone of (CHO-K1 
cells) (ATCC, Manassas, VA) containing a stabe insertion of the cyan fluorescent protein 
(CFP) gene sequence.  CHO-K1-CFP and Clone 9 cells were grown in Ham’s F12K 
medium supplemented with 2 mM L-glutamine (ATCC) and 10% fetal bovine serum 
(Gibco-Invitrogen, Carlsbad, CA).  HEK293 cells were grown in minimum essential 
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medium (Eagle) supplemented with 2 mM glutamine (ATCC) and 10% fetal bovine 
serum.  PC12 cells were grown in Ham’s F12K medium supplemented with 2 mM L-
glutamine, 15% horse serum and 2.5% fetal bovine serum.  HCT-116 cells were grown in 
McCoy’s 5a medium supplemented with 1.5 mM L-glutamine (ATCC) and 10% fetal 
bovine serum.  A10 and J774 cells were grown in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 4 mM L-glutamine (ATCC) and 10% fetal bovine serum.  
All cell media were additionally supplemented with 100 µg/ml of streptomycin and 100 
U/ml penicillin (Gibco-Invitrogen).  For experiments with sodium butyrate (NaB), cells 
were allowed to recover in their respective medium supplemented with a final 
concentration of 2 mM NaB (Sigma-Aldrich, St. Louis, MO). 
 
Vertically aligned nanofiber-mediated impalefection 
 
The method of impalefection has been previously described in detail (McKnight et al. 
2003b).  In this study, the technique was slightly modified and ultimately optimized in a 
number of parameters.  Briefly, cells were grown to near or full confluency in T25 or T75 
flasks and disassociated from the plastic substrate using Cellstripper™ (Mediatech, Inc.; 
Herndon, VA) and resuspended in 5 mls of the appropriate medium.  Cells were 
centrifuged at 300 x g for 10 minutes, medium was aspirated and the cell pellet was 
resuspended in 0.2-1.0 ml, depending on the application.  Cells were allowed to settle for 
5 minutes and impaled using inverted nanofiber (carbon or silicon) array chips of 2.2 mm 
x 2.2 mm size adsorbed with pd2EYFP-N1 plasmid.  The chip was then placed in 
inverted fashion in 200 µl of their respective, fully supplemented growth media in a 
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round-bottom well of a 96-well plate.  The plate was incubated at 37 ºC with 5% CO2 and 
allowed to recover for 18-24 hours. 
 
Optimization of impalefection substrate 
 
For experiments involving the optimization of the nanofiber composition (carbon or 
silicon), nanofiber pitch or impalement substrate (glass slide, polydimethylsiloxane 
(PDMS) pad, etc.), all other parameters were consistent.  Impalefections were performed 
as described above and five to ten replicate chips were used for each experimental 
variable.  For the impalement substrate experiments, 3” x 1” pre-cleaned glass micro 
slides were purchased from Corning (Corning, NY).  Compliant silicone pads were 
fabricated of polydimethylsiloxane (PDMS) using a commercially available two part mix 
(Sylgard 184, Dow Corning), mixed per manufacture’s specifications and poured on 
clean, 100-mm silicon wafers to ~3 mm thickness.  Following 30 minute cure at 65 deg 
C, PDMS pads were peeled from the silicon substrate and cut to individual pieces.  For 
the plastic impalement substrate, Costar® clear, non-treated flat-bottom 96-well plates 
(Corning Inc.; Corning, NY) were used with or without a 5 mm x 5 mm pad of Durx 770 
clean room wipes (Berkshire Corp.; Great Barrington, MA). 
 
Optimization of cell confluency 
 
CHO-K1-CFP cells were grown over 48 hours to differing levels of confluency (60%, 
termed subconfluent, or 100%, termed confluent).  To account for differences in cell 
 46
concentration, two T25 flasks of subconfluent cells were used alongside one T25 flask of 
confluent cells.  Cell preparation for impalement transfection was described above.  Cell 
pellets were similar in size, and cells were resuspended in 0.2 ml Ham’s F12K media.  
For cell impalement, approximately 50 µl of the cell suspension was spotted onto a glass 
slide, and cells were allowed to settle for 5 minutes.  For impalefection, 2 µl of DNA 
(pd2EYFP-N1, 5 ng/µl) were spotted onto each 041906_2 (Sesha, 20 µm pitch) nanofiber 
chip and allowed to dry.  Immediately after drying, each chip was wetted in Ham’s F12K 
media, then inverted and gently placed over the settled cells.  After pressing, each chip 
was placed face down in 200 µl of Ham’s F12K media in a round-bottom 96 well plate 
and the cells were allowed to recover for 24 hours.  Five duplicate samples were used for 
each variable. 
 
Optimization of DNA precipitation and concentration 
 
For optimization of DNA concentration, CHO-K1-CFP cells were grown to full 
confluency.  Nanofiber chips were either spotted or EDC-condensed with varying DNA 
concentrations (1 µg, 100 ng, 10 ng, 1 ng, or 100 pg).  EDC condensation was performed 
as previously described (Mann et al. 2007) with some modifications.  Briefly, each DNA 
concentration was aliquoted into 100 µl of MES buffer, pH 4.5, with 10 mg/ml EDC in 
one well of a 96-well plate.  The 96-well plate was rotated on a Lab Line 3-D Rotator for 
2 hours.  After 2 hours, each nanofiber chip was moved to a new well of the plate 
containing 200 µl of sterile H2O.  The chips were incubated in H2O for 2 min followed by 
the replacement of H2O with 100 µl of 2 M NaCl in PBS and incubated for 2 min once 
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again.  This washing step was repeated twice.  Finally, the nanofiber chips were placed in 
100 µl of PBS to prevent drying on the surface prior to cell impalement.  Spotted DNA 
chips were spotted with 2 µl of DNA (1 µg, 100 ng, 10 ng, 1 ng, or 100 pg) and allowed 
to dry.   Impalements were carried out described above, with five replicate carbon 
nanofiber chips for each variable.  As a negative control, three chips were incubated with 
100 ng of pd2EYFP-N1 in MES buffer without EDC.  For optimization of DNA 
precipitation, pd2EYFP-N1 was spotted and allowed to dry on nanofiber chips under a 
variety of conditions including DNA alone, DNA with 20 mM spermidine (Sigma-
Aldrich), DNA with 1M CaCl2 (Sigma-Aldrich), DNA with 20 mM spermidine and 1M 
CaCl2.  Additionally, pd2EYFP-N1 was dried and subsequently washed with ethanol 
(EtOH) (Sigma-Aldrich) or isopropanol (IPA) (Sigma-Aldrich) prior to impalefection.  
Impalefections were carried out as described above.  When testing DNA precipitation, 
each variable was repeated with five individual nanofiber chips of each type.  These 
DNA precipitation experiments were done simultaneously using chips from carbon 
nanofiber and black silicon nanofiber arrays. 
 
Optimization of Cell Concentration and Cell Washing 
 
In order to optimize the cell concentration of impalefection, CHO-K1-CFP cells were 
grown in T75 flasks to near confluency.  After dissociation, centrifugation and 
resuspension in fresh Ham’s F12K medium, cells were counted using a Beckman-Coulter 
Cell Counter (Fullerton, CA).  Cells were then pipetted into separate wells of a flat-
bottom 96-well plate containing Durx pad.  Three different cell concentrations were used:  
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1 x 104 cells, 1 x 105 cells, and 1 x 106 cells well-1.  Concurrently, the efficiency of a cell 
washing step immediately after impalefection was also investigated.  Briefly, five 
replicated nanofiber chips of each differing cell concentration were prepared in duplicate 
(for a total of ten nanofiber chips).  One set of these duplicate chips were placed 
immediately face down in 200 µl of fresh Ham’s F12K medium in a round-bottom 96-
well plate after the impalement step.  For the other set of duplicate nanofiber chips, after 
the impalement step each chip was placed in 200 µl of fresh Ham’s F12K medium and 
washed with a moderate degree of force for 5 seconds before being placed face down in 
200 µl of fresh Ham’s F12K medium in a round-bottom 96-well plate and allowed to 
recover. 
 
Impalefection Efficiency Measurements 
 
Impalefection efficiency was determined by counting the total population of cells on each 
nanofiber chip, and dividing it by the number of YFP-expressing cells present on the 
same chip.  Since CHO-K1 cells were stably expressing the CFP gene, cell counting 
could be done using direct observation using the inverted fluorescent microscope.  For all 
other cell types, chips were first counted for all YFP-expressing cells, and then incubated 
in fluorescein diacetate at a final concentration of 10 µM for 5 minutes.  This allowed for 
counting of the total population of cells on the chip.  For comparison of non-optimal and 
optimal impalefection efficiency, efficiency data from 234 carbon nanofiber-mediated 
impalefections of CHO-K1 cells were used.  Of these impalefection experiments, 117 
sample chips were used under a variety of non-optimized conditions, while 117 of the 
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sample chips were used under optimized conditions.  Optimized conditions are defined as 
carbon nanofiber arrays with 5 µm pitch, spotted with between 100 ng and 1 µg of non-
complexed pd2EYFP-N1, and pressed on Durx 770 clean room wipes in flat-bottom 96-
well plates into cells at near or full confluency.  Some cells were allowed to recover 
under the presence of 2 mM NaB.  These data were analyzed using SigmaPlot 10.0 
(Systat Software Inc., San Jose, CA).  For comparison of impalefection efficiency 
between the whole nanofiber chip and regions of the nanofiber chip, 24 separate carbon 
nanofiber-mediated impalefections of CHO-K1 were randomly chosen.  Since digital 
images of these impalefection experiments were previously recorded between 3/8/2007 
and 8/6/2007, the impalefection efficiency of the whole chip was already known.  In 
order to determine the regional efficiency, one region of the digital image was selected 
for each chip, containing no less than 20 total cells, and the impalefection efficiency of 
this region was calculated.  The regional efficiency was averaged for all 24 
impalefections, and then compared to the average whole chip efficiency of the same 
impalefection experiments. 
 
Fluorescence microscopy, cell staining and cell counting 
 
Cells were monitored and counted using a Nikon Diaphot 300 inverted fluorescent 
microscope (Nikon, Melville, NY) with filter sets for CFP (436 nm excitation, 480 nm 
emission) and YFP (500 nm excitation, 535 nm emission) purchased from Chroma 
Technology Corp. (Rockingham, VT; Cat. No. 31044v2 and 41028).  All nanofiber chips 
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were counted for total number of surviving cells on the chip and total number of cells 




For carbon nanofiber array synthesis, 4” silicon wafers (100) were photolithographically 
patterned with 50 nm thick Ni thin films as discrete 500 nm diameter dots at either a 5, 
10, or 20 μm pitch over the entire surface of the wafer.  Nanofibers were synthesized in a 
custom built DC-PECVD reactor at a temperature of 650 ºC, 10 torr, 2 A, using a mixture 
of a carbonaceous source gas (acetylene) and an etch gas (ammonia).  Growth time was 
selected to provide fibers ranging from ~10-17 μm tall, with tip diameters of ~100 nm.  
Spatially indexed arrays were subsequently spun with a 2 μm thick layer of SU-8 2002 
photoresist (Microchem Corp., Newton, MA) and patterned with a grid and numerical 
indexing using contact photolithography and development (SU-8 Developer, 
Microchem).  Following growth and index patterning, wafers were spun in a protective 
layer of photoresist (Microposit SPR220 CM 7.0, Shipley Corp., Marlborough, MA) and 
diced into 2.2 mm x 2.2 mm square chips.  Following dicing, the protective photoresist 
was removed by soaking in Microposit Remover 1165 (Shipley), followed by copious 
rinsing in water.  For silicon nanofiber array synthesis, silicon wafers (Silicon Quest 
International, Santa Clara, CA) were anisotropically etched in SF6/O2–based high density 
plasma at cryogenic temperatures. Briefly, wafers were loaded in an Oxford 100 
DRIE/RIE system capable of cryogenic processing. The wafers were cooled to -110 ºC 
and SF6/O2 gases were introduced. The ratio of fluorine molecules to oxygen molecules 
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was selected by using the black silicon method (Jansen et al. 1995). An RF 
electromagnetic field was then applied to the wafers, ionizing gas molecules and creating 
a plasma. During the subsequent etch process, native oxides, dust particulates, organics, 
and other contaminants on the wafer surface acted as micromasks. Underlying silicon 
was protected because of the anisotropic nature of the etch. This enabled the formation of 




All data for impalefection efficiency were calculated as means and standard deviation of 
the mean. For most experiments, determination of the statistical significance between 
different variables was made using Student’s t test in Microsoft Excel 2003 (Microsoft 
Corp., Redmond, WA).  For statistical comparisons of impalefection efficiency in 
different cell types, a nonparametric one-way ANOVA on the ranked data, and Kruskal-
Wallis Multiple Comparison Z test with Tukey-Kramer adjustment was done in NCSS 
(Number Crucher Statistical Systems, Kaysville, UT).  For all analytical results, a p value 




Results and Discussion 
 
Optimization of mechanical parameters 
 
Nanofiber composition.  The vertically aligned nanofiber array platform was optimized 
by experimenting with the nanofiber composition, the impalement substrate, and some 
technique oriented variables.  Traditionally, impalefection has been performed with 
carbon nanofibers.  However, recent synthesis of silicon nanofibers has shown potential 
application for useful DNA immobilization chemistry (unpublished data).  Carbon 
nanofiber arrays were investigated parallel to silicon nanofiber arrays using spotted DNA 
(Figure 2).  While there was a significant difference between the silicon and carbon 
nanofibers in the presence of CaCl2, spermidine and isopropanol (IPA), similar levels of 
efficiency for impalefection were observed for most of the variables tested.  While no 
significant difference could be seen among the other variables individually, carbon 
nanofibers did show a significantly higher impalefection efficiency over silicon 
nanofibers when all variables were averaged (8.5% ± 4.4% vs. 5.7% ± 2.8%, 
respectively.  p value = 0.002).  Therefore, carbon nanofibers were used for the remainder 
of the optimization experiments.  Worth noting is the fact that silicon nanofibers were not 
examined using DNA immobilization techniques (e.g. EDC condensation) that have been 
successful in the past on carbon nanofibers 1, 12.  This could potentially be addressed in 
future studies.   
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Impalement substrate.  The substrate used for impalefection has been a variety of flat 
surfaces in past studies including PDMS and wetted glass slides (McKnight et al. 2003b; 
McKnight et al. 2004b).  Additionally CHO-K1 cells have been centrifuged onto 
nanofiber arrays, although this step can be replaced with simply allowing the cells to 
settle onto the nanofiber chip prior to impalement, which was the method used 
throughout this study.  Different impalement substrates were investigated to test for 
differences and optimal qualities.  Impalements were performed on 1) a glass slide, 2) a 
PDMS pad, 3) a flat-bottom well from a 96-well plate, and 4) a flat-bottom well from a 
96-well plate containing Durx clean-wipe pad.  Each impalement substrate was examined 
and the efficiency of impalefection was calculated by dividing the total number of cells 
by the number of transfected cells expressing YFP (Table 2).  The glass slide and PDMS 
pad showed very low efficiency values (0.88% ± 1.91% and 1.71% ±  2.39%, 
respectively) when compared to the other variables.  On the other hand, the flat- bottom 
plate wells with and without Durx pad showed significantly higher impalefection 
efficiencies (6.44% ± 2.05% and 6.06% ± 1.30%, respectively).  This could be explained 
by the nature of the plastic flat-bottom plate with and without the Durx pad.  In the flat-
bottom plate, the cells are limited in movement due to the small size of the well.  
Additionally, the plastic surface may allow for cellular adherence, resulting in cells 
becoming immobilized to some degree prior to impalement.  The pore size and 
composition of the Durx pad allows for cells to settle in the crevices of the pad, similarly 
immobilizing them for the pressing step during impalefection.  This is not the case with 
the glass surface and PDMS pad.  The cells are not spatially limited and nanofibers can  
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Table 2.  Effects of cell confluency, impalement substrate, and sodium butyrate on 




often break off the chip when pressing against hard surfaces like glass.  Likewise, 
nanofibers can become embedded in plastic surfaces during impalement, making the 
Durx pad even more convenient as an impalement substrate. 
 
Optimization of chemical parameters 
 
DNA precipitation.  In traditional methods of gene delivery, the DNA is often 
precipitated or condensed using divalent or trivalent cations or alcohols (Behr et al. 1989; 
Knight and Adami 2003).  The enhancement of impalefection by the addition of a 
divalent cation (CaCl2), a trivalent cation (spermidine), and alcohol – ethanol (EtOH) or 
isopropanol (IPA) – were investigated (Figure 2).  Strikingly, no means of DNA 
precipitation  had an enhancing effect on impalefection efficiency, while spermidine and 
 CaCl2 or any combination of both resulted in decreased efficiency.  The addition of 
EtOH or IPA prior to impalement appeared to increase efficiency, but not by any 
significant degree.  This data suggests that DNA alone is sufficient for high impalefection 
efficiency, and was used for all further experimentation.  While this result was surprising, 
it also revealed the simplicity of the concept behind the impalefection method: DNA is 
simply being inserted mechanically into cells by physical means, often directly to the 
nucleus, and cells are subsequently allowed to recover and express the inserted genes.  
This explains why complexed DNA, often used to “disguise” the DNA for passage 
through the cell membrane or to protect the DNA from degradation once inside the cell, 





Figure 2.  Effects of different DNA precipitation methods on the impalefection 
efficiency of carbon and silicon nanofibers.  Experimental variables: 1) DNA, 2) DNA 
and CaCl2, 3) DNA and spermidine, 4) DNA and CaCl2 and spermidine, 5) DNA and 
CaCl2 and spermidine and IPA wash, 6) DNA and IPA wash, 7) DNA and EtOH wash.  * 
denotes a statistically significant difference (p < 0.05).  Error bars denote standard 




DNA concentration.  The efficiency of expression increased with increasing 
concentrations of DNA (Figure 3).  The efficiency of impalefection was significantly 
higher at DNA concentrations of 100 ng chip-1 and 1 µg chip-1 (15.06% ± 4.06% and 
12.92% ± 5.52%, respectively).  While impalefection efficiency increased at these DNA 
concentrations, successfully impalefected cells have been observed with as little as 20 pg 
of DNA chip-1.  Plasmid DNA was freshly prepared prior to these experiments, although 
the quality and purity of the DNA as well as the size of the plasmid could have differing 
effects on the impalefection efficiency.  These factors were not quantitatively examined 
during this study.  In addition, Figure 2 reveals that adsorbed DNA is impalefected into 
CHO cells at a higher efficiency than immobilized DNA.  This result was not surprising, 
due to the likely decreased amount of DNA that remains on nanofiber arrays after EDC-
condensation and successive washing steps.  Any DNA that is not covalently 
immobilized to the nanofibers is washed off the nanofiber array, resulting in a decreased 
amount of DNA when compared to nanofiber arrays that have been adsorbed with DNA.  
Quantitation and analysis of transcriptional availability of EDC-immobilized DNA will 
be addressed in future studies. 
 
Optimization of biological parameters 
 
Cell concentration and cell washing.  While washing can be a vital step in the 
impalefection process, decreasing the number of non-impalefected cells on the chip 
during the recovery period, extensive washing can also result in the dissociation and loss  
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Figure 3.  Effects of the concentration of adsorbed and immobilized DNA on 
impalefection efficiency.  * denotes a statistically significant difference (p < 0.05).  Error 
bars denote standard deviation with n = 5 for each variable. 
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of many loosely-attached impalefected cells from the array.  However, if the chip is not 
washed after impalement and prior to recovery, it can become overgrown with a 
population of non-impalefected cells that remained on the nanofiber array post-
impalement, depending on the initial cell concentration used for impalefection.  In order 
to experimentally address these issues, impalefections were carried out on different cell 
concentrations with and without the presence of a wash step.  While variations in cell 
concentration did not seem to have any effect on the impalefection efficiency (Table 3), 
the initial cell concentration did expectedly affect the resulting number of cells left on the 
nanofiber array after impalefection and recovery.  Therefore, if fewer impalefected cells 
or less confluent populations are desired for a particular study (i.e., longer assays 
requiring more space for cell growth over time), lower cell concentrations or short cell 
settling times (<5 minutes) should be used.  Likewise, if a high number of impalefected 
cells or confluent cell populations are desired, higher cell concentrations and longer cell 
settling times (>5 minutes) should be used.  Table 3 demonstrates that introducing a wash 
step immediately after the impalement step resulted in the loss of a substantial portion of 
cells, impalefected and non-impalefected.  In past studies, chips have been oriented 
upright in 30 mm or 60 mm dishes to allow access to nutrients in the medium during 
incubation.  Orientation of the chip during recovery can also affect the long-term viability 
and ability to track cells due to overgrown cell populations and agitation of the cells 
while inverting the chips for microscopic observation.  To overcome these difficulties, a 
new technique has been introduced.  Currently, the washing step has been removed and 
chips are placed in an inverted orientation in round-bottom 96-well plates for recovery.   
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Table 3.  Effects of cell concentration and cell washing on impalefection efficiency.     
* denotes a statistically significant difference (p < 0.05), and n is equal to 5 for each 
variable. 
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The round-bottom of the plate allows cells access to nutrients, while minimizing the 
settling and growth of non-impaled cells during the first 24 hours of recovery. 
 
Cell confluency.  In recent experiments, Noll et. al demonstrated that standard 
transfection methods (e.g. lipofection) resulted in higher levels of gene expression and 
protein production when cells were cultured to confluency prior to transfection than when 
cells were cultured to subconfluency (Noll et al. 2002).  Therefore, the effect of cell 
confluency on impalefection efficiency was investigated in CHO-K1 cells.  While 
differences in cell confluency did not have significant effects on impalement efficiencies 
(Table 2), slightly higher efficiency was seen with fully confluent cells when compared to 
subconfluent cells.  Whether this increase is due to cell cycle, cell physiology or simply 
cell number was not further investigated and remains unknown, but fully confluent cells 
were used for future experiments.  
 
Sodium butyrate.  Sodium butyrate (NaB) was investigated as an additive during the 
recovery of impalefected cells, due to its known ability to enhance specific gene 
expression and prolong transient gene expression post-transfection in mammalian cells 
(De Leon Gatti et al. 2007; Gorman et al. 1983).  Table 2 shows the impalefection 
efficiency of CHO-K1 cells in the presence and absence of NaB.  No significant 
difference with or without NaB was observed in the percentage of cells that expressed the 
transgene after impalefection.  However, the fluorescence of impalefected cells 
expressing YFP in the presence of NaB was visibly brighter when compared to the 
impalefected cells in the absence of NaB (data not shown).  While the impalefection 
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efficiency was not affected by its presence, NaB has still proven to be useful for extended 
transgene expression after impalefection, and will continue to be used for experiments 
where longer transient expression assays (72 hrs+) are desired. 
 
Cell type.  CHO-K1 cells have been used as a model cell line in the past due to their 
robust nature in cell culture and the ease with which they can be transfected.  In this 
study, numerous other cell types were tested using the optimized impalefection method.  
The impalefection efficiency in these different cell types are shown in Figure 4, and 
included a variety of human (HEK-293, HCT-116), rat (A10, Clone 9, PC12) and mouse 
 (J774) cell types.  HEK-293, PC12 and HCT-116 cells showed no significant difference 
in impalefection efficiency when compared with CHO-K1 (Anova analysis; d.f. = 70, F- 
ratio = 16.21, p = 0.00001), possibly due to the robust nature of all these cell types.  A 
slight increase was observed when PC12 cells were impalefected using VACNF arrays 
with a nanofiber pitch of 2.5 µm rather than 5 µm (data not shown).  This was likely due 
to the smaller diameter of PC12 cells.  A similar increase in impalefection efficiency was 
not observed when CHO cells were impalefected with 2.5 µm pitch nanofiber arrays.  
A10, Clone 9 and J774 cells showed significantly lower impalefection efficiency.  Very  
few viable cells could be observed on the nanofiber arrays 24 hours after impalement in 
these cell types.  Due to the physical nature of the impalefection technique, the variability 
of efficiency in different cell types is most likely not due to difference in cell surface, 
membrane composition or uptake pathways.  However, delivery to the cell nucleus is 
required for successful DNA expression following impalefection.  Therefore, differences  
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in nucleus size may contribute to the variability of efficiency observed.  Likewise, Clone 
9 cells have also shown resistance to liposome-based transfection methods used in our lab 
(data not shown), suggesting that this cell line may be more resistance to transfection in 
general.  Nonetheless, the results in Figure 4 demonstrate the applicability of the 
impalefection technique over a diverse range of cell lines.   
 
Evaluation of impalefection efficiency following optimization 
 
Once the technique was optimized, impalefection efficiencies were compared between 
the optimized parameters and a variety of non-optimized parameters.  Efficiencies were 
measured for 234 impalefection experiments of CHO-K1 (117 non-optimized samples 
and 117 optimized samples) and compared (Figure 5).  The distribution of efficiency 
values for the two methods illustrates an increased efficiency of the new optimized 
method that is statistically significant (p = 0.0004) when compared to the non-optimized 
method.  Additionally, these data demonstrate that the reproducibility has increased, as 
no efficiency values between 0.0% and 1.0% were observed for the optimized 
impalefection method.   
 
In biolistic bombardment or other physical or mechanical transfection methods, regions 
of cells rather than the entire cell culture population are counted for efficiency, due to 
non-uniform parameters for the entire cell culture.  This is rarely observed in chemical 




Figure 4.  Impalefection efficiency in different mammalian cell types.  * denotes a 
statistically significant difference (p < 0.05).  Error bars denote standard deviation with n 





Figure 5.  Comparison of efficiencies of the non-optimized and optimized 
impalefection method.  This box-whisker plot compares the efficiency values of 
impalefection samples using non-optimized parameters against impalefection samples 
using optimized parameters (n = 117 for each variable).  Black dots correspond to 
outliers.  There was a significant difference between the two values (p =  0.0004), 
determined using a p value < 0.05.  
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amounts of the transfection agent.  However, in biolistic processes often only a local 
region of the cell culture dish is successfully transfected, and the central region of the cell 
culture dish is often killed due to exposure to gas pressure (Novakovic et al. 1999).  
Therefore, the proportion of transfected cells is often determined only in regions of the 
cell culture.  This concept of regional efficiency can be applied to VACNF-mediated 
impalefection as well, due to the frequent observation of many cells on the nanofiber 
array chips, but only small regions of the chip containing impalefected cells.  This could 
be due to a number of factors, including loss of nanofibers on other regions of the chip, 
the pressing step taking place on an uneven surface, cells settling unevenly on the 
substrate, and misorientation of the nanofiber chip during impalement.  In order to 
evaluate the regional impalefection efficiency, 24 chips were selected and counted for 
regional proportions of expressing cells.  The results confirmed that the efficiency 
increased to 37.5% ± 11.5% in regions of the chip under optimal circumstances.  This is a 
significant increase from 9.6% ± 6.1% observed in optimized impalefections, and would 
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QUANTITATIVE ANALYSIS OF IMMOBILIZED DNA ON VERTICALLY 
ALIGNED CARBON NANOFIBER GENE DELIVERY ARRAYS 
 
This chapter is a modified version of a paper published with the same title in journal 
Biotechnology and Bioengineering in July 2007 by David Mann, Timothy McKnight, 
Anatoli Melechko, Michael Simpson and Gary Sayler. 
 
Mann, D.G.J., McKnight, T.E., Melechko, A.V., Simpson, M.L., Sayler, G.S. 2007.  
Quantitative Analysis of Immobilized DNA on Vertically Aligned Carbon Nanofiber 
Gene Delivery Arrays.  Biotechnology and Bioengineering, 97(4): 680-688. 
 
The use of the term “we” in this chapter refers to my co-authors and myself.  My primary 
contributions in this chapter were the following:  1) assisting in the experimental design 
of the PCR, IVT and qPCR investigations, 2) developing the PCR and qPCR primer and 
probe sets, 3) performing all experiments and assisting in data analysis, 4) gathering and 
reviewing the background literature and 5) writing the majority of the manuscript and 




There has recently been a heightened interest in the integration of synthetic, 
nanostructured materials with biological systems.  Use of such materials to deliver 
tethered, transcriptionally-active DNA into mammalian cells has enabled novel 
approaches to genetic manipulation.  This includes nuclear targeting of delivered DNA 
via heterofunctional metallic nanorods (Salem et al. 2003) and controlled, non-segregated 
transgene expression from arrays of nuclear-penetrant, vertically-aligned carbon 
nanofiber (VACNF) arrays (McKnight et al. 2003b; McKnight et al. 2004b).  This latter 
method, termed parallel impalefection, is a technique similar to microinjection, differing 
in that it can be conducted on a highly parallel basis to manipulate many cells 
simultaneously. Vertically-aligned carbon nanofibers with micron lengths and sub 100 
nm diameters are arrayed in parallel normal to the surface of a solid substrate.  Pressing 
this array into a cell or tissue matrix results in cellular penetration and ‘microinjection’ of 
surface-bound material into a large number of target cells.  Due to the nanoscale diameter 
of VACNFs, the plasma membranes of mammalian cells can recover following fiber 
penetration which enables the proliferation of the interfaced cell (McKnight et al. 2003b).  
Often, impalefection appears to result in direct nuclear delivery, particularly for 
suspended or unattached mammalian cells with large nuclear cross-sections as compared 
to the overall cross sectional area of the cell. 
 
Although DNA has been successfully delivered to mammalian cells using vertically 
aligned carbon nanofibers, the details of this process are still being investigated.  One 
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element of this process that has not been previously addressed is a quantitative 
determination of the amount of DNA immobilized on the nanofiber platform.  In previous 
work, plasmid DNA was tethered to impalefection arrays using a carbodiimide mediated 
condensation reaction between DNA base amines and carboxylic acid sites on nanofibers 
(McKnight et al. 2003b; McKnight et al. 2004b).  This approach has been effectively 
used for DNA immobilization onto a variety of substrates, including polymers (Taira and 
Yokoyama 2004), microwells (Rasmussen et al. 1991), glass slides (Zammatteo et al. 
2000), glass beads (Walsh et al. 2001), gold electrodes (Ge et al. 2003), carbon electrodes 
(Millan et al. 1992), carbon nanotubes (Dwyer et al. 2002; Nguyen et al. 2002) and 
carbon nanofibers (McKnight et al. 2003b).  Millan demonstrated that when using 1-
ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) for DNA immobilization to 
carbon, the amide bond is formed specifically at exposed guanine and cytosine amines 
(Millan et al. 1992).  Since DNA bound to carboxyl groups at these binding sites cannot 
be effectively directed, binding may occur at undesirable locations and might render the 
tethered DNA template transcriptionally-inactive.   
 
Covalent binding within or near the promoter region may also limit or eliminate 
transcription initiation due to steric hindrance of polymerase and/or transcription factor 
binding.  In the eukaryotic cell, transcription initiation is similarly impacted by steric 
hindrances imposed by ionic interactions between histones and DNA template, with, for 
example, acetylation of lysine residues of these chromatin proteins being a significant 
regulatory mechanism of gene expression (Latchman 2004).  Binding within the coding 
sequence may also interfere with reading and complementation of the base during mRNA 
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elongation.  Schaffer et al. found that the disassociation of noncovalent interactions 
between polycations and DNA was required for efficient expression of the DNA by 
transcriptional machinery (Schaffer et al. 2000).  In either case, the transcriptional 
activity of template can be significantly reduced, if not completely hindered by the 
interaction of the template with large molecules.  Therefore, tethered gene strategies, 
where solid scaffolding can present even larger hindrances, may present an additional 
variable with respect to evaluation of efficiency (i.e. transgene expression per unit DNA).  
Having knowledge of the amount of transcriptionally-active DNA that is successfully 
being delivered to cells will be helpful for future studies where the number of gene copies 
per cell will play a significant role.  In this manuscript, using impalefection-based 
nanofiber arrays as our substrate, we explore cell-free methods to obtain a first order 
approximation of the accessibility and transcriptional activity of immobilized DNA 
template by correlating the yields of PCR, quantitative PCR and in-vitro transcription 
(IVT) against that of unbound, free DNA. 
 
Materials and Methods 
 
Synthesis of Vertically Aligned Carbon Nanofiber Arrays 
 
Arrays of vertically-aligned carbon nanofibers were fabricated as previously described 
(Melechko et al. 2003).  In brief, 100 mm silicon wafers (n-type, <100>) were spun with 
photoresist [SPR 955 CM 0.7] and patterned with 500 nm diameter holes on a 2.5 μm 
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pitch using projection photolithography [GCA Autostep 200] and development 
[Microposit, CD26].  A 30 second reactive ion etch (RIE) [Trion Oracle, 150 torr, 50 
sccm oxygen, and 150 W of power] in oxygen plasma was used to remove residual resist 
from the developed regions. A Ni layer [500 Å] was deposited onto a wafer using 
electron-gun evaporation at 10-6 torr.  The excess metallization and photoresist was lifted 
off using a 1 hour soak in acetone, followed by rinsing in a spray of acetone, followed by 
2-propanol.  Vertically-aligned carbon nanofibers were then grown from the patterned Ni 
dots using dc catalytic plasma enhanced chemical vapor deposition (C-PECVD) 
(Melechko et al. 2003).  Typically, nanofibers were grown to a length of approximately 7 
μm with a conical shape featuring a tip diameter of < 100 nm and a base diameter of 200-
300 nm.  Following synthesis, wafers were coated with a protective layer of photoresist 
(SPR 220 CM 7.0) and cut with a dicing saw into sized pieces.  Prior to use, each piece 
was cleaned of the protective photoresist with a 30 minute soak in acetone, followed by 
rinse in acetone, 2-propanol, and water. 
 
Covalent Attachment of DNA to Carboxylated Microspheres and Vertically Aligned 
Carbon Nanofiber Substrate 
 
The DNA vector pd2EYFP-N1 (BD Biosciences) was transformed into DH5α E.coli cells 
and isolated using the Wizard Plus Miniprep Kit (Promega).  DNA was covalently 
attached to carboxylated beads using 100 ng of pd2EYFP-N1 vector (BD Biosciences) 
placed in 200 uL of 100mM 2-[N-morpholino]ethane sulfonic acid buffer (MES) (pH 
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4.7) containing 1 mg of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC).  1.0 μm 
polybead carboxylate microspheres (Polysciences, Inc., Warrington, PA) were added at a 
final concentration of 2.28 x 104 particles ml-1.  For VACNFs, 100 ng of pd2EYFP-N1 
were placed in 200 uL of 100mM 2-[N-morpholino]ethane sulfonic acid buffer (MES) 
(pH 4.7) containing 1 mg of EDC along with one carbon nanofiber chip (2 mm x 2 mm 
dimensions).  The carboxylate microspheres and nanofiber chips were incubated for 18 
hours at 25°C on an orbital shaker overnight to condense primary amines of the DNA to 
the carboxylic acid sites of the solid substrates (Dwyer et al. 2002; McKnight et al. 
2003b).  The carboxylate microspheres and nanofiber chips were then incubated in 1 ml 
of HPLC grade sterile H2O for 15 minutes followed by vortexing.  This washing step was 
repeated in 1 ml of 2M NaCl in PBS and once again in 1 ml of HPLC grade sterile H2O.  
This stepwise wash procedure was elected due to heterogeneity of the silicon and 
VACNF surfaces.  This heterogeneity presents difficulty with effectively removing 
nonspecifically bound DNA during washing.  Oxidized silicon behaves as conventional 
glass or glass-milk, requiring low salt solutions for DNA elution.  The heterogeneous 
charge and high surface area of carbon nanofibers appears to present both ionic as well as 
physical adsorption.  Thus, conventional approaches at optimizing salt concentrations are 
confounded.  Our methods were tested using three different salt concentrations, and a 
sequential water/2M NaCl/water was selected for this study.  For carboxylate 
microspheres, the samples were centrifuged after each wash in 1.5 ml microcentrifuge 
tubes (Eppendorf) for 2 min. at 16,000 x g in order to remove the microspheres from 
suspension.  Carboxylate microspheres and carbon nanofiber chips were also prepared in 
the absence of EDC as a negative control.  Sham silicon chips, without nanofibers, were 
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also prepared with and without EDC as additional negative controls.  These silicon chips 
without fibers result on each wafer in areas without Ni catalyst sites, as defined by the 
pregrowth Ni photolithographic patterning step.  Without Ni catalyst, these regions are 
unpopulated with nanofibers, but remain otherwise exposed to all other processing steps, 
including high temperature plasma, photoresist protection and acetone stripping. 
 
Primer and Probe Design for PCR and Quantitative PCR 
 
Three sets of primers (Sigma Genosys, St. Louis, MO) were constructed specifically for 
qualitative determination of amplifiable regions of the pd2EYFP-N1 vector when 
tethered to the carboxylate microspheres or carbon nanofiber chips (Table 4).  This 4.9 kb 
plasmid contains a CMV promoter upstream of the enhanced yellow fluorescent protein 
gene (eYFP).  The forward primer (YFP F1) was identical for all three primer sets.  The 
three reverse primers (YFP R1, YFP R2, YFP R3) were made to amplify 1) the CMV 
promoter region (amplicon = 648 bp), 2) the CMV promoter and eYFP gene (amplicon = 
1603 bp) and 3) a large fragment containing over 80% of the plasmid length (amplicon = 
4053 bp).  Additionally, two primer and probe sets (Biosearch Technologies, Novato, 
CA) were designed for quantitative determination of the pd2EYFP-N1 vector when 
tethered to the carbon nanofiber chips.  The first primer and probe set (YFP FQ, YFP RQ, 
YFP Probe1) amplifies a 72 bp region internal to the CMV promoter upstream of the 
EYFP gene.  The second primer and probe set (YFP FV, YFP RV, YFP Probe2)  
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Table 4. Primers and probes used in this study. 
 






5’-CCT GAT TCT GTG GAT AAC CGT AT-3’ 
5’-ATC TGA GTC CGG TAG CGC TA-3’ 
 
CMV Promoter 648 bp 
YFP F1 
YFP R2 
5’-CCT GAT TCT GTG GAT AAC CGT AT-3’ 
5’-AAA TGT GGT ATG GCT GAT TAT GAT C-3’ 
 
CMV Promoter 




5’-CCT GAT TCT GTG GAT AAC CGT AT-3’ 
5’-TAT ATA TGA GTA ACC TGA GGC TAT G-3’ 
 






5’-CAC CAA AAT CAA CG-3’ 
5’-ACG CCT ACC GCC CAT TT-3’ 
5’-6-FAM d(AAT GTC GTA ACA ACT CCG CCC 
CA)BHQ-1-3’ 
 






5’-CAA TTA GTC AGC AAC CAG G TG TG-3’ 
5’-CGG GAC TAT GGT TGC TGA CTA A-3’ 
5’-6-FAM d(CAG GCT CCC CAG CAG GCA GAA GTA 
T)BHQ-1-3’ 





amplifies a 97 bp region of the SV40 promoter, 200 bp upstream of the kanamycin 
resistance gene and 938 bp downstream of the CMV promoter and EYFP gene.    
 
PCR Amplification of pd2EYFP-N1 covalently-bound to Carboxylate Microspheres and 
Vertically Aligned Carbon Nanofibers 
 
The PCR reaction for the three amplicons was optimized by using temperature gradient 
protocols (45-60°C), different concentrations of primers and template DNA, as well as the 
Invitrogen PCR Optimization Kit.  The final mix of each PCR tube contained 1 Ready-
To-Go PCR Bead (Amersham Biosciences), 400 nM forward primer, 400 nM reverse 
primer, and HPLC grade sterile H2O.  For PCR amplification, the PTC-200 Peltier 
Thermal Cycler (MJ Research) was used.  The optimal temperature for all primer sets 
was 56°C.  Negative controls in the presence and absence of EDC were performed 
in duplicate via PCR amplification of the 648 bp CMV promoter region using chips 
selected from regions of the silicon growth wafer that were unpopulated with carbon 
nanofibers.  Negative control chips generated no detectable bands, thereby indicating that 
DNA binding is occurring to nanofiber sites and not the underlying Si substrate (data not 
shown).  For positive controls of pd2EYFP-N1, 10 ng of the vector was added to each 
reaction tube.  For amplification of pd2EYFP-N1 on carboxylate microspheres, 5 ul of 
the 2.28 x 104 particles ml-1 microsphere suspension were added to the reaction tube.  For 
amplification of pd2EYFP-N1 on a carbon nanofiber chip, the chip was placed directly 
into the reaction tube containing the Ready-To-Go PCR Bead, primers and HPLC grade 
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sterile H2O.  The final volume for all reaction tubes was 25 uL.  For gel electrophoresis, a 
1% agarose gel of molecular biology grade agarose (Fisher Science) was run at 70 volts 
for 45 minutes.  For the DNA ladder mix, 1 KB+ Ladder (Invitrogen) was mixed with 
HPLC grade sterile H2O and 5X bromophenol blue. 
 
In Vitro Transcription of pd2EYPF-N1 covalently tethered to Vertically Aligned Carbon 
Nanofibers 
 
In vitro transcription was performed using the HeLa Scribe Kit (Promega), following the 
protocol from the manufacturer.  Briefly, each nanofiber chip was added to 10 mM rNTP 
mix, 50 mM MgCl2, 20 mM HEPES (pH 7.9 at 25°C), 100 mM KCl, 0.2 mM EDTA, 0.5 
mM DTT, 20% glycerol and HeLa nuclear extract and incubated for 1 hour at 30°C.  
After the reaction was terminated by the addition of 0.3 M Tris-HCl (pH 7.4 at 25°C), 
0.3M sodium acetate, 0.5% SDS, 2 mM EDTA and 3µg/ml tRNA, the generated RNA 
was isolated using phenol chloroform extraction as described in the HeLa Scribe Kit.  
Samples were stored at -80°C.  Quantification of RNA in each sample was determined 
using the Ribogreen RNA Quantitation Kit (Molecular Probes, R-11490).  Samples were 
measured in triplicate on the VersaFluor Fluorometer (BioRad) using VersaFluor 
Cuvettes (BioRad).   
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Quantitative PCR of pd2EYFP-N1 on Vertically Aligned Carbon Nanofibers.   
 
DNA was immobilized on the VACNFs as described above.  Once pd2EYFP-N1 had 
been tethered to the carbon nanofiber arrays, the YFP F1 and YFP R2 primer set was 
used to amplify the CMV promoter and EYFP gene for three cycles of PCR.  Volumes 
containing carbon nanofiber arrays cannot be measured directly in quantitative PCR 
reactions due to the opacity of the nanofiber substrate. This initial step allowed 
amplification of pd2EYFP-N1 that was present on the carbon nanofibers to be amplified 
into solution, such that the chip could be removed for subsequent q-PCR.  Primers 
designed to amplify the CMV promoter and EYFP gene region were used for these initial 
PCR cycles because the promoter and gene region are what need to remain accessible to 
the cellular machinery following impalefection.   After the initial three rounds of PCR, 
the nanofiber chips were removed from the tube and a 5 µl aliquot of the PCR solution 
was then added to the quantitative PCR mix in place of the template DNA.  The 
quantitative PCR mix consisted of 400 nM of each primer (YFP FQ, YFP RQ), 600 nM 
of probe (YFP Probe1), and 1X Taq PCR Master Mix (Qiagen).  The pd2eYFP-N1 
plasmid was run as a standard in known amounts using 10-fold dilutions to generate a 
standard curve.  Positive controls of known amounts of template were run against the 
standard curve to verify the accuracy of this technique.  Quantitative real time PCR 




Results and Discussion 
 
PCR Amplification on Vertically Aligned Carbon Nanofibers 
 
PCR was used to determine the presence or absence as well as the accessibility of DNA 
on the nanofiber arrays after extensive washing steps.  Figure 6a shows that the CMV 
promoter region of pd2EYFP-N1 can be amplified when the DNA vector is putatively 
covalently tethered to nanofibers (lane 6).  Light bands can also be seen in the lane 5, 
where no EDC was present for covalent attachment, indicating retention of non-
specifically adsorbed DNA on the nanofibers.  In Figure 6b, it is shown that the larger 
region of the CMV promoter and EYFP gene sequence of pd2EYFP-N1 is also accessible 
for amplification after EDC condensation and extensive washing of the nanofiber chip 
(lane 6).  It is worth noting that the nanofiber chips incubated with DNA in the absence of 
EDC showed undetectable levels of amplifiable CMV promoter and EYFP gene (lane 5).  
Figure 6c shows the results of using primers (YFP F1, YFP R3) for amplification of 
approximately 80% of the pd2EYFP-N1 vector sequence.  No detectable levels of this 
length of the vector could be seen from the nanofiber arrays with DNA incubated in the 
presence or absence of EDC (lanes 5 and 6).  Similar results were observed with the 






Figure 6.  Amplification of pd2EYFP-N1 on vertically aligned carbon nanofiber 
arrays.  Amplified regions of pd2EYFP-N1 on both carbon nanofiber arrays and 
carboxylated latex beads using different primer sets.  Amplification of A) the CMV 
promoter region (648 bp), B) the CMV promoter and EYFP gene region (1603 bp) and C) 
80% of the vector length (4051 bp) of pd2EYFP-N1.  Lanes are identical for each PCR 
gel.  LANES: 1) 1 KB+ Ladder (Invitrogen), 2) 10 ng of non-tethered DNA, 3) 
Carboxylated microspheres without EDC, 4) Carboxylated microspheres with EDC, 5) 
Carbon nanofiber chip without EDC, 6) Carbon nanofiber chip with EDC, 7) non-








Figure 6.  (continued…) 
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In Vitro Transcription on Vertically Aligned Carbon Nanofibers 
 
Regardless of the evidence that DNA immobilized on carbon nanofibers is available for 
amplification, this does not mean that the DNA sequence of interest is also available for 
transcription in the cell.  To evaluate the transcriptional efficiency of pd2EYFP-N1 
covalently bound to the nanofiber arrays, in vitro transcription was performed.  Table 2  
shows a comparison of in vitro transcription of pd2EYFP-N1 in solution and on 
nanofibers in the presence or absence of EDC.  There was no significant difference 
between the transcription of RNA from nanofiber arrays bound with pd2EYFP-N1 in the 
presence of EDC (135 ± 44µg/µl) and the transcription of RNA from pd2EYFP-N1 in 
solution (177 ± 40 µg/µl).  Conversely, the transcriptional levels of RNA from pd2EYFP-
N1 on nanofibers bound in the absence of EDC were significantly lower (70 ± 4 µg/µl).  
These data are consistent with the results from the PCR assays.  Likewise, these results 
confirm previously reported data that tethered DNA is available to the transcriptional 
machinery of mammalian cells and can be expressed by these cells when introduced by 
means of impalefection (McKnight et al. 2003b; McKnight et al. 2004b). 
 
Quantitative PCR Amplification on Vertically Aligned Carbon Nanofibers 
 
Figure 6 indicates that pd2EYFP-N1 is covalently tethered to the carbon nanofiber 
arrays when incubated in the presence of EDC.  However, similar to a previous 
examination of the accessibility of immobilized DNA using polymerase chain reaction, 
the amount of immobilized DNA cannot be accurately estimated via conventional PCR  
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Table 5.  Quantification of RNA after in vitro transcription of pd2EYFP-N1 on 
vertically aligned carbon nanofiber arrays. 
 
Sample RNA (µg/µl) st. dev. 
Positive Control (No nanofibers) 176.7 ± 40.3 
Nanofibers with EDC 134.8 ± 44.2 
Nanofibers without EDC 69.9 ± 4.3 
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(Bulyk et al. 1999).  These data only provide a qualitative indication of DNA present on 
the nanofibers.  In order to assess how much DNA (e.g. copies of accessible CMV 
promoter and EYFP genes) remains on the nanofibers, we used quantitative PCR 
methods coupled to an initial three cycles of PCR as illustrated in Figure 7 and described 
in the methods.  These results are presented in Figure 8a.  Amplification yields of the 
CMV promoter and EYFP gene region of tethered DNA were quantified and compared to 
controls which were incubated in the absence of EDC. During the first round of 
quantification, approximately 1.6 x 109 gene copies were amplified from each nanofiber 
chip in the presence of EDC, while 7.9 x 108 gene copies were amplified from nanofiber 
chips in the absence of EDC. In subsequent reactions of the same nanofiber chips, DNA 
yields decreased dramatically (1.2 x 106 gene copies) on chips without EDC, while chips 
incubated in the presence of EDC retained DNA (5.6 x 108 gene copies) up to 10 days 
and 3 qPCR reaction cycles after initial covalent attachment.  The subsequent decrease in 
gene copies from these samples suggests that non-tethered DNA can remain non-
specifically adsorbed to the nanofibers during washing steps, but can be removed during 
thermal cycling.  
 
The results from Figure 8a also suggest that some portion of the pd2EYFP-N1 measured 
was the result of unbound plasmid, not amplification product.  Therefore, a set of primers 
and probe were designed which bound external to the CMV promoter and EYFP gene 
region that was being amplified during the three initial PCR cycles illustrated in Figure 7.  
This method was used to determine if the DNA measurements from Figure 8a were in 







Figure 7.  Illustration of the methods used for quantification of accessible DNA 





Figure 8.  Quantitative PCR of pd2EYFP-N1 on vertically aligned carbon nanofiber 
arrays.  These assays were used to determine how much DNA remains on the carbon 
nanofibers over time in the presence or absence of EDC.  The subsequent decrease in 
gene copies from carbon nanofibers incubated in the absence of EDC suggests that this 
DNA remained non-specifically adsorbed to the nanofibers after the wash steps and was 
removed during thermal cycling.   A) shows the number of EYFP gene copies amplified 
from the nanofiber using the internal primer and probe set (YFP FQ, YFP RQ and YFP 
Probe1) and B) shows the number of DNA copies released from the nanofiber arrays into 
solution and amplified using the external primer and probe set (YFP FV, YFP RV and 





Figure 8.  (continued…) 
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from the nanofibers during the reaction.  After these initial PCR cycles, this primer and 
probe set (YFP FV, YFP RV, YFP Probe2) were used for Taqman assays of real time 
quantitative PCR on the same samples used in Figure 8a.  The results are shown in Figure 
8b.  During the first reaction, there were high levels of DNA copies for both samples 
(EDC and no EDC).  These copies of DNA cannot be attributed to the first three PCR 
cycles, because the primer and probe set used bind to a region of the vector sequence 
found well outside the CMV promoter and EYFP gene region that were initially 
amplified.  These data would imply that those copies of DNA being quantified are 
equivalent to the number of pd2EYFP-N1 vectors being entirely released from the 
nanofiber arrays during the first three cycles of PCR.  These copies of the vector were not 
removed during the extensive washing steps.  The subsequent data from reaction 3 are 
consistent with the data in Figure 8a, showing that no significant amounts of DNA vector 
were amplified outside of the CMV promoter and EYFP gene region for either sample 
(EDC or no EDC), suggesting that the majority of DNA being amplified in reaction 3 
remained covalently tethered to the nanofiber arrays.   
 
Nanofibers have been previously used for DNA delivery into Chinese Hamster ovary 
cells (McKnight et al. 2003b; McKnight et al. 2004b).  Penetration and residence of 
DNA-modified nanofibers within the nucleus offers numerous possibilities for both gene 
delivery applications and the fundamental study of gene expression and transcriptional 
phenomenon.  For example, delivery of nanofiber-tethered DNA into a cell can offer a 
higher level of control over the fate of introduced genes, including the potential to 
remove these genes from a system after a period of transient expression simply by  
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removing the cells from the nanofiber array.  Nuclear delivery of tethered DNA on a 
parallel basis may also provide more efficient methods for studying the impact of 
template length and topology on transcriptional activity, which has traditionally been 
investigated through application of the serial method of microinjection (Harland et al. 
1983; Krebs and Dunaway 1996; Weintraub et al. 1986).  Similarly, nuclear-penetrant 
nanofiber arrays might be used for in-cell transcriptional assays based on immobilized-
template methods that have been developed for the study of in-vitro transcription using 
nuclear extracts (Adamson et al. 2003), thereby providing new levels of insight into the 
fundamental processes of transcription and transcriptional regulation.   
 
In prior work, DNA was typically bound to the nanofiber arrays using EDC 
condensation.  While this method for DNA attachment is rapid and simple, it is also 
relatively random in where it will attach the amine groups of the individual DNA strand 
to the carboxyl groups available on the carbon nanofiber.  This study shows that simple 
molecular techniques such as PCR, in vitro transcription and quantitative PCR can be 
used to efficiently evaluate EDC condensation and other DNA immobilization methods 
on nanoscale substrates.  The PCR results provided a qualitative evaluation of how 
accessible the DNA remains after condensation.  The IVT results were consistent with 
PCR, showing that after extensive washing, high levels of DNA remained accessible and 
could be utilized by both DNA and RNA polymerase.  The results of the quantitative 
PCR showed that in the presence of EDC, large quantities of accessible DNA remained 
tethered to the VACNF arrays for at least 10 days and through 3 subsequent qPCR 
thermal cycling sessions.  While 5.6 x 108 gene copies per chip is only a fraction of the 
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DNA that was originally attached (approximately 2.98 ng of the initial 100 ng), it is still a 
substantial amount.  For example, the VACNF array samples used in this study contained 
approximately 1 million fibers.  Therefore every fiber likely contained more than 500 
accessible gene copies.   
 
The PCR results in Figure 6 show that amplification decreases as the amplicon becomes 
larger.  While tethered pd2EYPF-N1 vector on these nanofiber chips is evidenced by the 
yields of shorter amplicons, long stretches of DNA cannot be amplified, indicating that 
they are not accessible to the polymerase enzyme during PCR. It is possible that this is 
due to steric hindrance or stalling of bound RNA and DNA polymerases.  Stalling of 
RNA polymerase II can occur in vivo during transcription due to DNA lesions (Yu et al. 
2003) or nucleotide-specific binding of proteins (Bertin et al. 1992).  Likewise, DNA 
polymerase has been shown to stall during DNA amplification due to stable secondary 
structures from base repeats (Krasilnikova et al. 1998) or bulky DNA lesions (Yan et al. 
2004).  Although no studies have examined the integrity of DNA for polymerization or 
transcription following covalent immobilization on a substrate, it can be assumed that 
stalling of the polymerase enzyme does occur under these circumstances.  This 
explanation would be consistent with the results of Figure 6, where amplification of the 
DNA template decreased as the amplicon became larger.  As the amplicon increases in 
size and more nucleotide bases are required during elongation, there is a higher 
probability that these base amines will be randomly immobilized to the available 
carboxyl groups on the VACNFs due to stochastic fluctuations in the helical structure of 
the DNA.  Figure 9 illustrates various binding modalities of DNA with VACNFs.  In 
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Figure 9a, the template DNA is initially tethered to the nanofiber, but will be removed 
during the washing steps or subsequent experimentation.  Figure 9b illustrates DNA 
template that is tethered to the nanofiber, but the gene region is not fully accessible for 
primer annealing or polymerase binding.  In this case, fragments of the gene may have 
base amines bound to carboxyl sites of the carbon nanofiber, restricting access to the 
DNA sequence.  Large stretches of DNA (i.e. the large 80% plasmid amplicon of 
pd2eyfp-n1) may not be amplified or transcribed due to the limited binding to the 
nanofiber that is required for these sequences to still be accessible.  Figure 9c shows the 
desired scenario, when DNA is covalently bound to the nanofiber in multiple locations, 
giving it resilience during the experimentation, while retaining an available gene 
sequence that can be accessed by the cellular machinery.  
 
 The results of the real time quantitative PCR show that over a period of 10 days and 3 
subsequent thermal cycling sessions, there are three orders of magnitude more DNA 
copies remaining on the nanofiber chips in the presence of EDC compared to 
thenanofiber chips incubated without EDC.  This is consistent with the qualitative data 
from the PCR gels, verifying that more accessible DNA is retained on the nanofibers 
when incubated in the presence of EDC.  However, the qPCR results from day 1 show 
that a large amount of DNA is initially adsorbed to the nanofiber chips without EDC, 
even after extensive washing.  These results were not observed in Figure 6, although they 




Figure 9.  Illustration of potential immobilization of DNA on vertically aligned 
carbon nanofiber arrays.   A) The template DNA is weakly tethered to the nanofiber at 
only one or two binding sites, and will be removed during the washing steps or 
subsequent experimentation.  B) The DNA is tethered to the nanofiber, but the gene 
region is not fully accessible for primer annealing or polymerase binding.  C) This is the 
desired scenario, where DNA template is covalently bound to the nanofiber in multiple 




results could be a result of differences in salt concentrations and oligonucleotide content 
between the PCR and qPCR mixes, both of which have been shown to affect the binding 
efficiency of DNA (Castelino et al. 2005; Huang et al. 1996). 
 
Other DNA binding strategies are currently being evaluated, including the use of short 
linear DNA constructs featuring biotin, thiol, and amine terminations.  Enhancing the 
binding strategies could result in fewer DNA molecules being needed and less DNA 
being released from the nanofiber arrays, as well as yielding a higher percentage of 
successful delivery and expression inside the cell.  It is anticipated that the combination 
of PCR, IVT, and qPCR assays presented in this manuscript along with the evaluation of 
engineered linear constructs with well defined site-specific binding properties, will 
provide insight into steric hindrances and other interfering properties of the solid 
scaffolding.   In addition to their evaluation with nanofiber based DNA delivery systems, 
it is anticipated that these same analysis methods will prove useful for other 
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INDUCIBLE RNAI-MEDIATED GENE SILENCING USING VERTICALLY 
ALIGNED CARBON NANOFIBER GENE DELIVERY ARRAYS 
 
 
This chapter is a modified version of a paper published with the same title in journal ACS 
Nano in January 2008 by David Mann, Timothy McKnight, Jackson McPherson, Peter 
Hoyt, Anatoli Melechko, Michael Simpson and Gary Sayler. 
 
Mann D.G.J., McKnight T.E., McPherson J.T., Hoyt P.R., Melechko A.V., Simpson 
M.L., Sayler G.S. 2008. Inducible RNA Interference-Mediated Gene Silencing Using 
Nanostructured Gene Delivery Arrays. ACS Nano, 2(1): 69-76. 
 
The use of the term “we” in this chapter refers to my co-authors and myself.  My primary 
contributions in this chapter were the following:  1) assisting in the experimental design 
of the investigations, 2) performing all experiments and assisting in data analysis, 3) 





Gene delivery to mammalian cells has become a staple of biological studies in the last 
few decades.  A number of nanostructured platforms have been shown to effectively 
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deliver plasmid DNA into mammalian cells, including nanofibers (McKnight et al. 
2003a; McKnight et al. 2004b), nanotubes (Cai et al. 2005b; Pantarotto et al. 2004), 
nanorods (Salem et al. 2003) and nanoparticles (Bauer et al. 2004; Zhi et al. 2006).  
Recent demonstrations have shown that vertically aligned carbon nanofiber arrays 
(VACNFs) grown on a silicon substrate can be used as a parallel gene delivery platform 
in mammalian cells (McKnight et al. 2003a).  In this process, termed impalefection, 
plasmid DNA is spotted or covalently immobilized on the nanoscale carbon fibers.  
Subsequently, mammalian cells are impaled onto the VACNFs, recover, and express the 
introduced genes.  During impalefection, single mammalian cells attach and proliferate 
on the nanostructured platform and can be tracked using spatial indexing of VACNF 
arrays (McKnight et al. 2004b).  Highly parallel introduction of DNA directly into 
mammalian cells and facile monitoring of the gene expression within individual cells 
over time are distinct advantages of impalefection when compared to traditional 
transfection methods.  Thus, the VACNF platform also allows for rapid and efficient 
transient assays of gene expression while tracking individual cells over time.  
Additionally, DNA immobilized on VACNFs may minimize the potential for 
incorporation of foreign genes into the chromosomes of manipulated cells (Mann et al. 
2007; McKnight et al. 2003a).   
 
Coupled with nucleotide delivery methods, RNA interference (RNAi) has become a 
powerful tool for controlling gene expression in many different cell types.  First 
discovered in Caenorhabditis elegans, the RNAi pathway is an evolutionarily conserved 
cellular mechanism that specifically down-regulates gene products post-transcriptionally 
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(Fire et al. 1998b).  The pathway has now been identified in most eukaryotes (Hannon 
2002).  The RNAi pathway has been extensively studied and well reviewed in the 
literature (Hammond 2005; Hannon and Rossi 2004; Karagiannis and El-Osta 2005).  
RNAi targets long double-stranded RNAs (dsRNAs), which are cleaved into ~21 to 24 
base pair small-interfering RNAs (siRNAs) by the RNase III enzyme Dicer (Bernstein et 
al. 2001b).  The siRNAs are coupled with an enzyme complex referred to as the RNA-
induced silencing complex (RISC) (Hammond et al. 2000), and effectively target the 
RISC complex to complementary mRNA transcripts which are cleaved and degraded by a 
process called post-transcriptional gene silencing (PTGS) (Zamore et al. 2000).  
Although the major function of RNAi seems to be as a viral defense mechanism, siRNAs 
may also silence transposable elements and repetitive genes to help stabilize the genome 
(Novina and Sharp 2004).  More recently, the RNAi pathway has been exploited for 
therapeutic approaches in human diseases (Kim and Rossi 2007), including age-related 
macular degeneration (Check 2005; McFarland et al. 2004).   
 
Introducing long dsRNAs into mammalian cells can cause a cytotoxic reaction by 
triggering a type-I interferon response and shutting down genome-wide translation, 
resulting in cell death (de Veer et al. 2005; Manche et al. 1992).  The interferon response 
can be avoided by introducing siRNAs directly to the cells, resulting in efficient silencing 
of the target genes (Kariko et al. 2004; Kim et al. 2004).  Additionally, DNA vectors 
expressing siRNA sequences as short inverted repeats (termed short hairpin RNAs, or 
shRNAs) have been developed and shown to stably down-regulate gene expression of 
targeted genes (Brummelkamp et al. 2002).  These shRNA vectors include designs for 
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constitutive and inducible gene silencing in mammalian cells (Bantounas et al. 2004; 
Fewell and Schmitt 2006).  For inducible shRNA expression, a tetracycline induction 
system is most commonly used (Ito et al. 2006; Kappel et al. 2007; Lin et al. 2004; 
Matsukura et al. 2003b) and is well reviewed in the literature (Berens and Hillen 2003; 
Ramos et al. 2005).  
 
For tetracycline inducible expression, the RNA polymerase III promoter for the histone 1 
(H1) gene can be altered to contain two Tet operator (tetO2) sites, and used to express the 
shRNA sequence. TetO2 sites bind the tetracycline repressor protein (TetR), which 
represses the transcription of downstream shRNA sequences.  However, when 
tetracycline is administered to the cells, it binds tightly to TetR generating a 
conformational change that displaces TetR from tetO2 sites.  With TetR gone, the H1 
promoter is no longer repressed, allowing transcription of the shRNA sequence. This 
results in generation of “induced” siRNAs that can specifically silence a targeted gene.   
 
Conventional tetracycline inducible approaches involve generating stable cell lines which 
express one or more elements of the induction pathway.  In addition to a cell line 
expressing the protein to be silenced, subclones of this line transgenically expressing the 
TetR protein and the shRNA construct are needed.  For negative controls, additional lines 
expressing non-sense or mismatched shRNA elements are prepared.  Positive controls 
include cells which do not express the repressor protein. The generation and screening of 
these stable cell lines is not a trivial process, requiring significant time (4+ weeks) and 
effort prior to evaluating the effects of any inducible RNAi on a cell system. 
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In this study, we investigated the application of VACNF arrays as a platform for the rapid 
assay of tetracycline-inducible RNAi-mediated gene silencing using the cyan fluorescent 
protein (cfp) gene expressed in Chinese hamster ovary (CHO-K1) cells.  Using the 
parallel gene-delivery capabilities of VACNFs, the yellow fluorescent protein (yfp) gene 
was simultaneously delivered with an inducible shRNA sequence to allow observation of 
successfully impalefected cells (Figure 10).  Using the VACNF platform for transient 
assays of gene expression and silencing we followed both nanofiber-mediated gene 
delivery and tetracycline induction of gene silencing within individual CHO-K1 cells. 
Cells were tracked using spatially indexed patterns on VACNF arrays.  This is the first 
demonstration of co-transfection of multiple DNA vectors using carbon nanofibers as a 
delivery tool, as well as the first manipulation of shRNA-mediated gene silencing on 
nanostructured architectures. 
 
Materials and Methods 
 
 
Plasmids, construction and maintenance 
 
Strains and plasmids used in this study are listed in Table S1.  Plasmids were maintained 
in E. coli strain JM109 and stored at -80ºC.  E. coli strain JM109 was grown in Luria-
Bertani (LB) broth at 37°C with or without ampicillin (100 µg/ml) or kanamycin (50 
µg/ml), depending on the requirements for plasmid maintenance.  Plasmids were 




Figure 10.  Illustration of the vertically aligned carbon nanofiber single-cell gene 
silencing platform.  (A) Nanofiber-mediated impalefection was used to deliver the yfp 
gene and CFP-silencing shRNA sequence into CHO-K1 cells that constitutively express 
the cfp and tetR genes (CHO-K1-CFP-TetR).  TetR represses the expression of the CFP-
silencing shRNA in the absence of tetracycline.  Once tetracycline is added to the system, 
it binds TetR, allowing expression of the shRNA and induced silencing of CFP 
expression.  Expression of the yfp gene allows for direct observation of impalefected 
cells.  (B) This VACNF platform allows for monitored silencing in single cells among a 
non-silenced cell population. 
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DNA (~100 ng/µl) was added to 100 µl of freshly thawed chemically competent E. coli 
strain JM109 cells on ice.  After 30 minutes, the cells were heat shocked at 42ºC for 45 
seconds and immediately placed on ice for 2 minutes.  Following transformation, 1 ml of 
2XYT medium was added and cells were allowed to recover at 37°C with shaking at 200 
rpm for at least 1 hour.  Cells were then plated on LB-agar plates with ampicillin or 
kanamycin and colonies were selected and screened for the correct insert 18-20 hours 
later.  Plasmid isolation was performed using Wizard mini- or midi-prep kits (Promega, 
Madison, WI).  The expression vectors pd2EYFP-N1 containing destabilized enhance 
yellow fluorescent protein (yfp) and pd2ECFP-N1 containing destabilized enhanced cyan 
fluorescent protein (cfp) were purchased from Clontech (Mountain View, CA).  The 
expression vector for the tetR gene (pcDNA6/TR) was purchased from Invitrogen 
(Carlsbad, CA).  pCFPQuiet was constructed using the pENTR/H1/TO vector from 
Invitrogen.  Using the BLOCK-iT™ Inducible H1 RNAi Entry Vector Kit from 
Invitrogen, a 50-bp oligonucleotide (5’-
CACCGCATCAAGGCCAACTTCAAGACGAATCTTGAAGTTGGCCTTGATGC-3’) 
containing a complementary sequence to the cfp gene from pd2ECFP-N1 was ligated into 
pENTR/H1/TO and resulted in the pCFPQuiet expression vector.  This DNA sequence 
was selected using the Invitrogen BLOCK-iT™ RNAi Designer website 
(https://rnaidesigner.invitrogen.com/sirna/).  In addition to the shRNA sequence specific 
for the cfp gene sequence, the pCFPQuiet vector also contains the Zeocin resistance gene 
for mammalian selection.  A negative control expression vector (pLacZQuiet) was 
constructed from the pENTR/H1/TO vector which contained a 49-bp oligonucleotide (5’- 
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CACCAAATCGCTGATTTGTGTAGTCGGAGACGACTACACAAATCAGCGA-3’) 
containing a complementary sequence to the lacZ gene.  This DNA sequence was 
included in the BLOCK-iT™ Inducible H1 RNAi Entry Vector Kit.  All constructed 
vectors were confirmed for the correct DNA sequence using M13 forward and reverse 
primers.  DNA sequencing was performed with an ABI Big Dye Terminator cycle 
sequencing reaction kit on an ABI 3100 DNA sequencer (Perkin-Elmer, Inc., Foster City, 
CA) at UT-MBRF (Knoxville, TN). 
 
Cell culture and reagents 
 
Chinese hamster ovary (CHO-K1BH4) cells were maintained in Ham’s F-12 (Gibco-
Invitrogen) and Ham’s F-12K (ATCC, Manassas, VA) media supplemented with 5% 
fetal bovine serum  (FBS), 100 µg/ml of streptomycin, 100 U/ml penicillin and 250 ng/ml 
amphotericin B under an atmosphere of 5% CO2 at a temperature of 37°C.  Cells were 
grown to confluence and passed every 4-5 days by trypsinization at a ratio of 1:9.  The 
selection agents blasticidin-s (5 µg/ml) and Zeocin (300 µg/ml) (Invitrogen, Carlsbad, 
CA) were used on appropriate cell lines.  Sodium butyrate was used in the media at a 
final concentration of 2 mM where mentioned below. 
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Cell transfection and generation of stable cell lines 
 
Cells grown in 35 mm wells were transfected with 1 µg of the pd2ECFP-N1 expression 
vector.  All cell transfections were achieved using the Fugene 6 transfection reagent 
(Roche Diagnostics, Indianapolis, IN) in accordance with the manufacturer’s instructions.  
The cells were then cultured in the presence of G 418 sulfate (EMD Biosciences Inc., San 
Diego, CA) and resistant colonies were passed after 14 days of treatment.  20 separate 
single clones from the population were obtained through isolation by limiting dilution in 
96 well plates.  The cell lines from each clone were examined for CFP expression by 
fluorescent microscopy.  The brightest fluorescent cell line was chosen (termed CHO-K1-
CFP) and stocks were made and stored at -80°C.  CHO-K1-CFP was then used to create 
the cell line CHO-K1-CFP-TetR by transfecting the cells with 1 µg of pcDNA6/TR.  The 
cells were cultured in the presence of 5 µg/ml blasticidin-S, and a single clone was 
isolated as described above.  The cell line (CHO-K1-CFP-TetR) was examined for TetR 
expression by RT-PCR and the results were positive (data not shown).  CHO-K1-CFP-
TetR was then used to create CHO-K1-CFP-TetR-CFPQuiet by transfecting the cells 
with 1 µg of pCFPQuiet.  These cells were cultured in the presence of 5 µg/ml 
blasticidin-S and 300 µg/ml of Zeocin, and a single clone was isolated as described 
above.  In similar fashion, the CHO-K1-CFP-CFPQuiet cell line was generated from 
CHO-K1-CFP.  An additional cell line (CHO-K1-CFP-LacZQuiet) was generated as a 
negative control to CHO-K1-CFP-CFPQuiet.   
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Multilabel counting analysis and tetracycline induction 
 
Cells were seeded at 1.0 x 105 in 6-well plates and allowed to attach overnight at 37°C in 
an incubator with atmosphere of 5% CO2.  After 24 hours of growth, tetracycline was 
added to cells every 3 hours for a 27 hour time period.  At 27 hrs, all wells were 
thoroughly washed with PBS three times.  200 µl of Cell Stripper (Mediatech Inc., 
Herndon, VA) were added to each well and allowed to incubate for 30-35 minutes.  After 
dissociation, cells were resuspended and pipetted into each well of a 96-well flat-bottom 
plate.  The plate was covered with a Breathe-Easy™ sealing membrane (Fisher Scientific 
Co. L.L.C., Pittsburgh, PA) and centrifuged at 400 x g for 15-20 seconds.  The multiwell 
plates were assayed as previously described with slight modifications (Green and Rasko 
2002).  Briefly, 96-well black clear-bottom plates were read using a Wallac Victor2 1420 
Multilabel Counter (Perkin Elmer Life Sciences, Waltham, MA).  Absorbance was 
measured at 450 nm for 1.0 second, followed by a fluorescence reading using a CFP filter 
set with an excitation of 436 nm and emission of 480 nm (Chroma Technology Corp., 
Rockingham, VT).  Readings were taken 8 mm from the bottom of the plates with a 0.5 
second measuring time.  The lamp control was on a stabilized energy setting, and all 
reads were obtained at 35,000 volts of lamp energy.  The relative fluorescence units 
described in this study were determined as follows:  Fluorescence in each cell line could 
not be measured on the plate reader from monolayers at optimal levels of confluence (60-
80%), due to the low level of CFP fluorescence.  Likewise, the cell fluorescence could 
not accurately be determined at higher levels of confluency (~100%), due to changes in 
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cellular expression that resulted in lower fluorescence of the stably inserted cfp.  Due to 
these limitations and variations, cells were maintained at 50-60% confluence in each well 
for the tetracycline induction experiments, and prepared as described above.  Standard 
curves of cell number versus absorbance were generated for each individual cell line 
between 1 x 104 and 1 x 106 cells, and the slope from each of these standard curves was 
used to extrapolate the estimated number of cells in each well based on the absorbance 
measured.  Additionally, the fluorescence was measured for each well, and normalized 
using the absorbance to determine the estimated fluorescence per cell, measured in 
relative fluorescent units (RFU). 
 
Fluorescence microscopy and cell counting 
 
Cells were observed and counted on chips using a Nikon Diaphot 300 or Nikon Eclipse 
TE300 inverted fluorescent microscope, depending on the experiment.  Filter sets on both 
microscopes for CFP (436 nm excitation, 480 nm emission) and YFP (500 nm excitation, 
535 nm emission) were purchased from Chroma Technology Corp. (Rockingham, VT; 
Cat. No. 31044v2 and 41028).  Digital imaging was performed using a MicroPublisher 
3.3 CCD camera integrated with QCapture 2.60 imaging software (QImaging Corp., 
Surrey, BC, Canada), and a Nikon Coolpix 4500 digital camera with a Scopetronix 
MaxView Plus attachment on the microscope eyepiece lens.  For the QImaging system, 
all images of CFP were obtained using an exposure time of 5 seconds.  Bright field 
images were obtained using an exposure time of 6.49 milliseconds.  For the Nikon 
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Coolpix system, all images of CFP were obtained using an exposure time of 2 seconds.  
Images of YFP were obtained using exposure times between 2 and 8 seconds, due to the 
varying levels of YFP fluorescence expressed by the cells.  This variation did not affect 
the statistical data of CFP expression, since YFP was only used as a biomarker of gene 
delivery.  For population counting of tetracycline-induction of shRNA silencing in CHO-
K1-CFP-TetR cells, ten replicate VACNF array chips were used for each variable.  For 
each chip, four images were taken and the total YFP-expressing cells were counted by 
hand.  Each YFP-expressing cell was then confirmed for the presence or absence of CFP.  
The presence of CFP was defined as any fluorescence that could be detected in the CFP 




Cells were trypsinized and resuspended in 5 ml of Ham’s F12K media.  Cells were 
centrifuged at 300 x g for 10 minutes.  The media was aspirated and the cell pellet was 
resuspended in 0.2-1.0 ml, depending on the size of the pellet and the specific 
application.  For each test sample, 100 microliters of the cell suspension was allowed to 
settle for 5 minutes on a 5 mm x 5 mm pad of clean room wipes (Durx 770, Berkshire 
Corp) in multiple wells of a 96-well plate.  Once the cells were settled, the nanofiber chip 
was slowly lowered face down and lightly placed on top of the settled cells.  The chip 
was then sharply tapped with flame-sterilized tweezers, and placed face down in 200 µl 
of Ham’s F12K with 2 mM sodium butyrate in a round-bottom well of a 96-well plate.  
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The 96-well plate was placed in an incubator at 37ºC with 5% CO2 and allowed to 
recover for 24 hours. 
 
Nanofiber Array Synthesis 
 
4” silicon wafers (100) were photolithographically patterned with 50 nm thick Ni thin-
films as discrete 500 nm diameter dots at either 5, 10, or 20 μm pitch over the entire 
surface of the wafer.     Nanofibers were synthesized in a custom built DC-PECVD 
reactor at a temperature of 650 ºC, 10 torr, 2 A, using a mixture of a carbonaceous source 
gas (acetylene) and an etch gas (ammonia).  Growth time was selected to provide fibers 
ranging from approximately 10 μm to 17 μm tall, with tip diameters of approximately 
100 nm.  Spatially indexed arrays were subsequently spun with a 2 μm thick layer of SU-
8 2002 (Microchem Corp., Newton, MA) and patterned with a grid and numerical 
indexing using contact photolithography and development (SU-8 Developer, 
Microchem).  Following growth and index patterning, wafers were spun in a protective 
layer of photoresist (Microposit SPR220 CM 7.0, Shipley Corp., Marlborough, MA) and 
diced into 2.2 mm square pieces.  Following dicing, the protective photoresist was 






All data were analyzed using Microsoft Excel.  The student t-test was used to determine 
statistical significance. 
 
Results and Discussion 
 
CFP temporal silencing in CHO-K1 cell populations by tetracycline-inducible shRNAs 
 
Multiple DNA vectors and cell lines were constructed to investigate the tetracycline-
inducible gene silencing capacity of shRNAs against the cyan fluorescent protein (CFP) 
mRNA in CHO-K1 cells (Table 6).  The shRNA sequence had high specificity for CFP, 
and did not silence YFP or GFP. This specificity is due to a two base pair difference 
within the targeted sequence of these fluorescent variants (data not shown) and is 
important because the yfp gene was used later in this study as a marker alongside the 
CFP-silencing shRNA vector (pCFPQuiet).  The specificity of the pCFPQuiet vector in 
silencing CFP was also tested by comparing it to pLacZQuiet, a shRNA vector targeting 
the lacZ gene sequence.  pCFPQuiet significantly decreased CFP expression levels when 
transfected into CHO-K1 cells while pLacZQuiet did not (data not shown).   
 
Next, the inducibility of pCFPQuiet was determined.  Figure 11a and b show pCFPQuiet 
is induced in CHO-K1 cells (CHO-K1-CFP-shRNA-TetR) using tetracycline (1 µg/ml)  
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Table 6.  DNA vectors and cell lines used in this study. 
 
This studyCHO-K1-CFP with stable chromosomal insertion of 
pLacZQuiet vector, phenotype is fluorescent cyan color
CHO-K1-CFP-
LacZshRNA
This studyCHO-K1-CFP-shRNA with stable chromosomal 
insertion of tetR gene from pcDNA6/TR vector, 




This studyCHO-K1-CFP with stable chromosomal insertion of 




This studyCHO-K1-CFP with stable chromosomal insertion of 




This studyCHO-K1 with stable chromosomal insertion of cfp gene 
from pd2ECFP-N1 vector, phenotype is fluorescent 
cyan color
CHO-K1-CFP
ATCCDerived as a subclone from the parental CHO cell line 
initiated from a biopsy of an ovary of an adult Chinese 
hamster ATCC# CCL-61
CHO-K1
This studypENTR/H1/TO vector harboring a 50 bp sequence from 
the lacZ gene downstream of the H1/TO promoter
pLacZQuiet
This studypENTR/H1/TO vector harboring a 50 bp sequence from 
the cfp gene downstream of the H1/TO promoter
pCFPQuiet
InvitrogenMammalian expression vector containing the tetR gene, 
constitutive CMV promoter, contains the Blasticidin
resistance gene and pUC origin and Amp resistance for 
E. coli
pcDNA6/TR
InvitrogenMammalian vector for shRNA expression, inducible 
polymerase III H1/TO promoter, contains the Zeocin






Mammalian expression vector containing the 
destabilized cyan variant (d2ECFP) of the enhanced gfp
gene, constitutive CMV promoter, contains a Neomycin 
G418 resistance gene and pUC origin and Kan 





Mammalian expression vector containing the 
destabilized yellow variant (d2EYFP) of the enhanced 
gfp gene, constitutive CMV promoter, contains a 
Neomycin G418 resistance gene and pUC origin and 









Figure 11.  Tetracycline induction of silencing in CHO-K1 cells over time in the 
absence (A, B) or presence (C, D) of sodium butyrate (NaB).  Cell lines used are 
represented as:  CHO-K1-CFP-TetR-shRNA (■), CHO-K1-CFP-TetR (▲), CHO-K1-
CFP (●) and CHO-K1-CFP-shRNA (♦) in A and C.  The average was determined from 
five individual replicates at each time point.  RFU = Relative Fluorescence Units.  
Standard deviation is shown in bars.  Measurements were normalized as described in the 
Supplementary Information.  Fluorescent micrographs of cells in the absence (B) or 
presence (D) of NaB are also shown at 0, 12 and 24 time intervals.  Bar represents 100 




Figure 11.  (continued…) 
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and efficiently silences CFP over time. Data were quantified using multilabel counting 
and inverted fluorescence microscopy.  At 24 hours, approximately 89.8% of the CFP 
fluorescence was silenced when compared to the negative controls.  When tetracycline 
was removed, CFP expression did not return to wild type levels again until an additional 
120 hours after tetracycline removal, which suggests a high level of potency of the 
siRNAs cleaved from the shRNAs (Figure 12).   
 
In addition, tetracycline induction of shRNA-mediated silencing was carried out in the 
presence of sodium butyrate (NaB).  NaB is a short-chain fatty acid that has been shown 
to inhibit histone deacetylase activity, and can result in enhancement of specific gene 
expression in CHO-K1 cells (De Leon Gatti et al. 2007), including genes under the 
control of the cytomegalovirus immediate early (CMV IE) promoter (Palermo et al. 
1991).  In this study, NaB was used to enhance the expression of the cfp gene on VACNF 
arrays and to increase the longevity of transient expression after transfection in 
mammalian cells (Gorman et al. 1983).  NaB temporarily enhanced and prolonged 
transgene expression resulting in a 4- to 8-fold increase in CFP fluorescence, but did not 
affect the time constants of CFP-silencing (Figure 11c and d).  Therefore, NaB was used 
during all subsequent impalefection experiments. 
 
Silencing of CFP by tetracycline-inducible shRNAs in cell populations on VACNF arrays 
 
To examine the use of VACNF arrays as a platform for regulated expression of CFP-
silencing shRNAs, pCFPQuiet was impalefected into CHO-K1-CFP-TetR cells, along 
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Figure 12.  Addition and removal of tetracycline to CHO-K1-CFP-TetR-shRNA 
cells over time.  A) CHO-K1-CFP-TetR-shRNA cells in the absence of tetracycline over 
time.  B) CHO-K1-CFP-TetR-shRNA cells in the presence of tetracycline.  Tetracycline 
(1 µg/ml) was added at time 0 hours and cells were monitored for CFP silencing.  Once 
CFP silencing was fully induced at 24 hours, tetracycline was removed from the media 
and cells were allowed to recover CFP expression.  Expression was not fully recovered 





Figure 12.  (continued…)   
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with pd2EYFP-N1, a vector containing the destabilized enhanced yellow fluorescent 
protein (yfp) gene.  yfp was used as a marker gene, to designate which cells were 
successfully impaled and received DNA.  Codelivery of more than one DNA vector using 
impalefection had never been addressed prior to this study,  thus the optimal DNA 
concentration of coexpression after impalement were determined.  Gene expression was  
studied by codelivery of either 10 ng or 100 ng of pd2EYFP-N1 and varying amounts 
(0.1, 1, 10 and 100 ng) of pd2ECFP-N1.  Wild type CHO-K1 cells were impalefected 
with both plasmids, allowed to recover for 24 hours, and counted using inverted 
fluorescence microscopy.  By comparing the number of cells expressing one or both 
genes to the total number of impalefected cells, the optimal concentration was established 
as 100 ng of each vector, resulting in 76.7% ± 3.9% codelivery of both genes (yfp and 
cfp) (data not shown).  This was significantly higher than the co-transfection rate using 
10 ng of each DNA plasmid (61.87% ± 10.80%).   
 
While successful impalefections have been seen with DNA concentrations as low as 20 
pg and some successful multi-plasmid impalefections were seen with DNA 
concentrations as low as 1 ng (data not shown), our current study shows that higher DNA 
concentrations will significantly improve the proportion of multiple-vector impalefected 
cells when using VACNFs.    The optimized DNA concentration of 100 ng each was used 
for codelivery of pCFPQuiet and pd2EYFP-N1 into CHO-K1-CFP-TetR cells, containing 
the stably inserted cfp and tetR genes.  Ten replicates of VACNF array chips (3 mm x 3 
mm) were used for each variable.  pCFPQuiet and pd2EYFP-N1 were impalefected into 
the cells. pLacZQuiet, was used as a negative control.  After 24 hours of recovery, 
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tetracycline was added and fluorescent cell counts began (time = 0 hours).  Significant 
levels of silencing (53.1% ± 10.4%) were observed 48 hours after addition of tetracycline 
(Figure 13). These data show that VACNF arrays can be used for highly efficient 
simultaneous delivery of multiple DNA plasmids to mammalian cells.  Notably, these 
levels were not as substantial compared with the results from the multilabel counting 
method used in Figure 11a and c.  This is due to the counting methods used.  Using 
multilabel counting, the estimates of shRNA-mediated silencing were based upon whole 
population fluorescence measurements. In this experiment, each chip expressing YFP 
was counted, and then each cell was observed for CFP expression.  This method results in 
a conservative estimate of shRNA-mediated silencing, because a number of the cells 
exhibiting low level silencing effects and lower levels of CFP expression may still be 
counted as CFP positive.  In addition, some cells were still expressing DNA up to 7 days 
after impalefection, which is longer than a typical transient transfection will last, 
suggesting stable chromosome insertions.  Importantly, these data show that inducible 
shRNA vectors can be incorporated into VACNF-mediated gene delivery systems.   
 
Gene silencing by tetracycline-inducible shRNAs monitored in a single cell on indexed 
VACNF arrays 
 
We additionally investigated whether tetracycline-inducible shRNA regulation of CFP 
expression could be monitored in single cells over time. Using indexed VACNF arrays, 
CHO-K1-CFP-TetR cells were impalefected with pCFPQuiet and pd2EYFP-N1 (10 ng of 
each) using VACNF arrays with nanofibers at a 20 µm pitch and an XY indexing pattern.   
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Figure 13.  Silencing of vertically aligned carbon nanofiber impalefected cells after 
tetracycline induction over time.  CHO-K1-CFP-TetR cells were impalefected with 
pd2EYFP-N1 (black), pd2EYFP-N1 and pLacZQuiet (gray), or pd2EYFP-N1 and 
pCFPQuiet (white).  Methods used for calculating cell counts are described in the 
discussion.  The average was determined from ten individual replicates at each time 
point.  Standard deviation is shown in bars.  (*) denotes statistical significance (p < 0.05). 
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Controls were performed by impalefecting CHO-K1-CFP-shRNA-TetR with 10 ng each 
of pCFPQuiet and pd2EYFP-N1 (positive control) and CHO-K1-CFP-TetR with 10 ng of 
pd2EYFP-N1 (negative control).  After 24 hours of recovery, tetracycline was added  
(time = 0 hours) and at least 50 individual cell trajectories were photographed and tracked 
every 24 hours.  As expected, single CHO-K1-CFP-TetR cells expressing the shRNA and 
yfp marker gene were silenced for CFP expression at 24 and 48 hours, while the same 
cells expressing only the yfp marker gene were not (Figure 14).  Figure 14 shows 
representative images where virtually every CHO-K1-CFP-shRNA-TetR cell was 
silenced at 24 and 48 hours.  Cells appear at different positions in each image, because 
CHO-K1 cells adhere to the surface of the substrate, but continue to move over time.  The 
relatively long time interval between pictures and the small plane of view (100µm x 
100µm) give the impression that the cells are moving large distances. Some cells are lost 
during handling of the VACNF chips between incubators and the microscope.   
Currently, VACNF array chips are incubated inverted in round-bottom 96-well plates, 
and require transfer to flat-bottom wells for microscopic observation.  Due to the high 
surface area of the carbon nanofibers and poor diffusion of media, the cells cannot 
survive on VACNF array chips inverted in flat-bottom wells.  Efforts are underway to 
develop better substrates for cell culture and microscopic observations. 
 
This study is the first to establish the ability with VACNFs to simultaneously introduce 
multiple foreign genes into a single cell among a population of cells, and track the  
exogenously controlled expression of genes over time within a 72 hour period. This 
contrasts with other studies that are limited to observing phenotypic changes in a single 
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Figure 14.  Tetracycline induction and tracking of YFP expression and shRNA-
mediated silencing of CFP expression in single impalefected cells on indexed 
vertically aligned carbon nanofiber arrays over time.  CHO-K1-CFP-TetR cells were 
impalefected with a) pd2EYFP-N1, b) pd2EYFP-N1 and pCFPQuiet and c) CHO-K1-
CFP-TetR-shRNA cells were impalefected with pd2EYFP-N1.  The top panel shows cells 
viewed using the CFP filter set; the bottom panel shows cells viewed using the YFP filter 
set.  Tetracycline (1 µg/ml) was added at time 0 hours and cells were monitored for CFP 
silencing at 0, 24 and 48 hours.  White arrows denote the original CFP-expressing cell, 








Figure 14.  (continued…) 
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cell over time, or a few studies that observed phenotypic changes in a single cell among a 
population of genotypically different cells over time (Valiunas et al. 2005).  Additionally, 
impalefection is a rapid method to generate and track stably transfected cells en masse. 
Using traditional methods, the generation of stable cell lines alone would require a 
minimum of 10-14 days.  While microinjection could be used for this same approach, it 
would be much more tedious to microinject multiple cells to be tracked over time.  In the 
current impalefection study, approximately 25-30 discrete, single cell trajectories were 
tracked for each VACNF chip (data not shown).   
 
We are currently investigating observations that yfp gene expression occurs as early as 75 
minutes after impalefection in CHO-K1 cells.  This is remarkable when considering the 
maturation time for wild type GFP is ~3 hours at room temperature (Rekas et al. 2002). 
Even when newer fluorescent protein genes with shorter maturation times are considered 
(Tsien 1998), our data suggest that the introduction and expression of the yfp gene in our 
system is extremely rapid and efficient.  We hypothesize that the impalefection process 
delivers high gene copy numbers directly to the nucleus, similar to microinjection, 
allowing for nearly immediate transcription and translation.  This may be the fastest 
method available for assaying gene silencing, and could be an important advancement for 
assays using siRNAs or micro RNAs (miRNA) expressed from shRNA or similar 
vectors.  Other transfection methods have significantly longer periods of time prior to 
gene expression, due to several factors including the need for internalization of the DNA, 
localization to the nuclear membrane, decomplexation of the DNA from its carrier, and 
nuclear import, some or all of which must occur prior to the initiation of transcription.  In 
 125
contrast, we have shown that the fast transcriptional initiation of impalefection, along 
with the specific tracking of individual cells and longevity of transient expression in the 
presence of NaB, allow for very rapid, and persistent assays of regulated gene expression 
in mammalian cells without the generation of stable clones. 
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Through this series of investigations mechanical, chemical and biological parameters of 
the VACNF-mediated transfection method were optimized for higher efficiency, the 
transcriptional activity of EDC-immobilized DNA on VACNF arrays was analyzed and 
quantified, and VACNF arrays were successfully used as nanoscale probes for gene 
delivery and modulation of gene expression in a single cell as well as populations of 
cells.  Based on the findings of this study, the following conclusions were drawn: 
 
• For mechanical parameters, the optimal impalement substrate was demonstrated 
to be plastic flat-bottom well containing a Durx™ 770 filter pad for cells to settle 
onto prior to impalement.  Carbon nanofibers had a higher overall impalefection 
efficiency than silicon nanofibers. 
• For chemical parameters, the optimal amount of adsorbed or immobilized DNA 
on carbon nanofiber arrays was between 100 ng and 1 µg per chip.  Adsorbed 
DNA showed significantly higher impalefection efficiencies when compared to 
EDC-immobilized DNA. 
• For biological parameters, the washing of cells after impalefection significantly 
decreased the impalefection efficiency.  The impalefection efficiency in HEK293, 
HCT-116 and PC12 cells showed no significant difference when compared to the 
standard cell line CHO-K1.  The impalefection efficiency of A10, Clone 9 and 
J774 cells was significantly lower than CHO-K1. 
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• Multiple parameters including DNA precipitation, cell confluency, cell 
concentration, and presence or absence of sodium butyrate demonstrated no 
significant impact on the efficiency of impalefection in CHO-K1 cells.   
• DNA covalently bound to carbon nanofibers can be amplified in PCR reactions.  
The CMV promoter and EYFP gene region of tethered pd2eYFP-N1 were readily 
amplified, while the longer sequence consisting of 80% of the vector length could 
not be amplified from the carbon nanofiber arrays.   
• In vitro transcription assay showed that DNA bound to carbon nanofibers can be 
accessed by transcriptional machinery such as RNA polymerase.   
• Using quantitative real time PCR assays, the promoter and gene region of tethered 
pd2eYFP-N1 were easily amplified and the number of DNA copies bound to 
carbon nanofibers in the presence of EDC (5.6 x 108 gene copies) were 
significantly higher than in the absence of EDC (1.2 x 106 gene copies).   
• DNA can adsorb non-specifically to carbon nanofibers in the absence of EDC and 
can remain adsorbed even after extensive washing.  However, this non-
specifically adsorbed DNA is rapidly removed over time. 
• A tetracycline-inducible shRNA vector (pCFPQuiet) can efficiently knockdown 
the expression of a stably expressed reporter gene (cfp) in Chinese Hamster Ovary 
(CHO-K1-CFP-TetR) cells in less than 24 hours.  After removal of tetracycline, 
the expression of the cfp gene returns to constitutive levels at 120 hours. 
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• Following impalefection and tetracycline induction of populations of CHO-K1-
CFP-TetR cells, 53.1% ± 10.4% of impalefected cells were fully silenced by the 
inducible CFP-silencing shRNA vector. 
• The delivery of the pCFPQuiet vector to CHO-K1-CFP-TetR cells on indexed 
VACNF arrays via impalefection provides the ability to not only track specific 
gene delivery events in discrete, single cells over extended periods of time 
without constant observation under the microscope, but it additionally provides 
the ability to control the expression of the delivered genes by turning them “on or 
off” using tetracycline induction among a population of cells that remain 
uninduced. 
 
Using the optimized impalefection method, the reproducibility and efficiency have 
significantly increased.  Furthermore, efficiency is much higher if specific regions of 
cells on the VACNF chip arrays are counted, as is often done for biolistic bombardment 
efficiency counts.  During the optimization process, very few parameters seemed to have 
a significant impact on the resulting impalefection efficiency.  This result could be due to 
the nature of the impalefection method.  Impalefection is not limited by cell confluency 
or cell concentration.  Impalefection efficiency may potentially increase in cell lines other 
than CHO-K1 under cell-line specific optimization of parameters.  Additional parameters 
such as nanofiber pitch may also play a role in impalefection efficiency of specific cell 
lines and should be addressed in future studies.  These results, along with the success of 
impalefection in numerous cell types, demonstrate that nanofiber-mediated impalefection 
is a versatile means of gene delivery under a broad range of experimental circumstances. 
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PCR, IVT and qPCR have proven to be highly beneficial methods for analyzing the 
presence and amount of DNA on VACNF arrays.  Additionally, these techniques provide 
a means of efficiently evaluating the site specific activity of tethered DNA constructs and 
thus provide a means for optimizing DNA attachment methods such as EDC 
condensation or biotin labeling, which are both currently being used in biological 
applications.  Optimization of current protocols and investigations of other binding 
strategies are presently being assessed to create more efficient DNA delivery systems.  
The surface chemistry of DNA on nanofibers composed of silicon should be further 
characterized in future studies as well, due to the ease of synthesizing vertically aligned 
silicon nanofiber arrays.  This could result in potentially increased ease of fabrication 
with no significant impact on the efficiency of impalefection.   
 
While the initial studies helped characterize the method of impalefection, the RNAi-
mediated gene silencing indexed array platform demonstrated the applicability of the 
VACNF impalefection process.  In this study, the specific target gene suppression of the 
RNAi pathway was combined with the gene delivery platform of VACNFs to investigate 
the silencing efficacy in nanostructure-immobilized and spatially indexed cell culture.  
VACNF arrays provided a mechanism for extremely rapid expression, silencing, and 
tracking in single cells of interest.  This VACNF-mediated technique can be used for a 
variety of applications as nanoscale probes that provide for gene delivery and modulation 
of gene expression in a single cell to overcome limitations and help address new types of 
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